<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
<front>
<journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id><journal-id journal-id-type="pmc">plosbiol</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Biology</journal-title></journal-title-group><issn pub-type="ppub">1544-9173</issn><issn pub-type="epub">1545-7885</issn><publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="publisher-id">09-PLBI-RA-5489R2</article-id><article-id pub-id-type="doi">10.1371/journal.pbio.1000453</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Developmental Biology</subject><subject>Genetics and Genomics/Animal Genetics</subject><subject>Genetics and Genomics/Epigenetics</subject><subject>Molecular Biology/Histone Modification</subject><subject>Physiology/Reproductive Physiology</subject></subj-group></article-categories><title-group><article-title>MLL2 Is Required in Oocytes for Bulk Histone 3 Lysine 4 Trimethylation and Transcriptional Silencing</article-title><alt-title alt-title-type="running-head">Oocyte MLL2 Is Required for Female Fertility</alt-title></title-group><contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Andreu-Vieyra</surname><given-names>Claudia V.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="fn" rid="fn1"><sup>¤</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chen</surname><given-names>Ruihong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Agno</surname><given-names>Julio E.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Glaser</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anastassiadis</surname><given-names>Konstantinos</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Stewart</surname><given-names>A. Francis</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Matzuk</surname><given-names>Martin M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, United States of America</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Genomics, BioInnovationsZentrum, Technische Universitaet Dresden, Dresden, Germany</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Walter and Eliza Hall Institute, Melbourne, Australia</addr-line>       </aff><aff id="aff4"><label>4</label><addr-line>Center for Regenerative Therapy, Technische Universitaet Dresden, Dresden, Germany</addr-line>       </aff><aff id="aff5"><label>5</label><addr-line>Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America</addr-line>       </aff><aff id="aff6"><label>6</label><addr-line>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America</addr-line>       </aff><contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Reik</surname><given-names>Wolf</given-names></name>
<role>Academic Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group><aff id="edit1">The Babraham Institute, United Kingdom</aff><author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">mmatzuk@bcm.edu</email> (MMM); <email xlink:type="simple">francis.stewart@biotec.tu-dresden.de</email> (AFS)</corresp>
<fn fn-type="con"><p>The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: CVAV SG KA AFS MMM. Performed the experiments: CVAV SG KA. Analyzed the data: CVAV. Contributed reagents/materials/analysis tools: AFS MMM. Wrote the paper: CVAV AFS. Revised the manuscript: CVAV MMM. Maintenance of mouse colonies/genotyping: RC JEA. Performed studies in the Tamoxifen-Cre line and preliminary studies in Mll2 hypomorph; designed original Mll2 KO and Floxed alleles: SG KA.</p></fn>
<fn fn-type="current-aff" id="fn1"><label>¤</label><p>Current address: Department of Urology, USC Norris Comprenhensive Cancer Center, Los Angeles, California, United States of America</p></fn>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="collection"><month>8</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>17</day><month>8</month><year>2010</year></pub-date><volume>8</volume><issue>8</issue><elocation-id>e1000453</elocation-id><history>
<date date-type="received"><day>22</day><month>12</month><year>2009</year></date>
<date date-type="accepted"><day>2</day><month>7</month><year>2010</year></date>
</history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2010</copyright-year><copyright-holder>Andreu-Vieyra et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract abstract-type="toc">
<p>Conditional knockout mouse strategies identify the histone methyltranferase MLL2 as a key player in epigenetic reprogramming of female gametes.</p>
</abstract><abstract>
<p>During gametogenesis and pre-implantation development, the mammalian epigenome is reprogrammed to establish pluripotency in the epiblast. Here we show that the histone 3 lysine 4 (H3K4) methyltransferase, MLL2, controls most of the promoter-specific chromatin modification, H3K4me3, during oogenesis and early development. Using conditional knockout mutagenesis and a hypomorph model, we show that <italic>Mll2</italic> deficiency in oocytes results in anovulation and oocyte death, with increased transcription of p53, apoptotic factors, and <italic>Iap</italic> elements. MLL2 is required for (1) bulk H3K4me3 but not H3K4me1, indicating that MLL2 controls most promoters but monomethylation is regulated by a different H3K4 methyltransferase; (2) the global transcriptional silencing that preceeds resumption of meiosis but not for the concomitant nuclear reorganization into the surrounded nucleolus (SN) chromatin configuration; (3) oocyte survival; and (4) normal zygotic genome activation. These results reveal that MLL2 is autonomously required in oocytes for fertility and imply that MLL2 contributes to the epigenetic reprogramming that takes place before fertilization. We propose that once this task has been accomplished, MLL2 is not required until gastrulation and that other methyltransferases are responsible for bulk H3K4me3, thereby revealing an unexpected epigenetic control switch amongst the H3K4 methyltransferases during development.</p>
</abstract><abstract abstract-type="summary"><title>Author Summary</title>
<p>It is well established that gametes and early mammalian embryos undergo extensive epigenetic changes, which are changes in phenotype or gene expression that do not entail changes in DNA sequence. However, the machinery responsible for epigenetic modification in these situations is poorly understood. In mice, we conditionally deleted the histone 3 lysine 4 (H3K4) methyltransferase <italic>Mll2</italic>, an enzyme that alters DNA structure and packaging, either in gametes or in somatic cells of the ovary and also produced a mouse hypomorph expressing low levels of MLL2. We show that MLL2 is required in oocytes during gametogenesis and is also needed as a maternally derived factor during early development. Oocytes deficient in <italic>Mll2</italic> display decreased methylation of H3K4 (H3K4me3) and show abnormal maturation and gene expression, in particular of pro-apoptotic factors. In addition, we demonstrate that embryonic genome activation is compromised in the absence of <italic>Mll2</italic>. Together our results identify MLL2 as one of the key players in the epigenetic reprogramming required for female fertility in the mouse.</p>
</abstract><funding-group><funding-statement>This work was supported in part by National Institutes of Health grant HD33438 (to MMM), a Lalor Foundation fellowship (to CVA-V), the EU 6th Framework Integrated Program, HEROIC (LSHG-CT-2005-018883; to AFS), and the Deutches Forschung Gemeinschaft Schwerpunktprogram SPP1356, Pluripotency and Reprogramming (to AFS). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="19"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Mammalian epigenomes are fundamentally reprogrammed during gametogenesis and pre-implantation development to establish the ground state of pluripotency in the epiblast cells of the blastocyst <xref ref-type="bibr" rid="pbio.1000453-DeLaFuente1">[1]</xref>–<xref ref-type="bibr" rid="pbio.1000453-Nichols1">[5]</xref>. Despite the importance of this epigenetic reprogramming, how such changes are achieved is not well understood. Epigenetic reprogramming of the maternal genome occurs during oogenesis. Oocytes develop synchronously from birth until puberty, during which time they are arrested in meiotic prophase I, increase in size, and are transcriptionally active until the peri-ovulatory stage, when they undergo global transcriptional silencing <xref ref-type="bibr" rid="pbio.1000453-Matzuk1">[6]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Edson1">[7]</xref>. Transcription of the oocyte genome serves to establish the reservoirs of maternal components that are required for the first stages of embryonic development <xref ref-type="bibr" rid="pbio.1000453-Schultz1">[8]</xref>. Global transcriptional silencing in oocytes is thought to be required for the efficient resumption and completion of meiosis <xref ref-type="bibr" rid="pbio.1000453-Liu1">[9]</xref> and occurs parallel to large-scale chromatin condensation and rearrangement around the nucleolus to establish a chromatin configuration termed SN (surrounded nucleolus) <xref ref-type="bibr" rid="pbio.1000453-DeLaFuente1">[1]</xref>,<xref ref-type="bibr" rid="pbio.1000453-BouniolBaly1">[10]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Debey1">[11]</xref>. Previous studies showed that global transcriptional silencing can occur without the establishment of the SN state <xref ref-type="bibr" rid="pbio.1000453-DeLaFuente1">[1]</xref>,<xref ref-type="bibr" rid="pbio.1000453-DeLaFuente2">[12]</xref>. Further studies indicated that both the acquisition of the SN configuration and transcriptional silencing are pre-requisites to achieve full embryonic developmental potential <xref ref-type="bibr" rid="pbio.1000453-Zuccotti1">[13]</xref>,<xref ref-type="bibr" rid="pbio.1000453-DeLaFuente3">[14]</xref>.</p>
<p>Chromatin and epigenetic changes during oocyte development include histone variant exchange, alterations of DNA methylation, and global shifts in histone post-translational modifications. For instance, maternal-specific genomic imprints are established on a locus-by-locus basis <xref ref-type="bibr" rid="pbio.1000453-Schaefer1">[15]</xref>–<xref ref-type="bibr" rid="pbio.1000453-Reik2">[19]</xref>, the linker histone 1 variant H1FOO is incorporated into chromatin <xref ref-type="bibr" rid="pbio.1000453-Tanaka1">[20]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Tanaka2">[21]</xref>, and the global levels of 5-methyl-cytosine (CpG DNA methylation) and histone 4 acetylation at lysine 5 and 12 (H4K5 and H4K12) increase <xref ref-type="bibr" rid="pbio.1000453-Kageyama1">[22]</xref>. In addition, the levels of di- and tri-methylation of histone 3 at lysines 4 and 9 (H3K4me2/3 and H3K9me2/3), which are associated with active and repressed gene expression, respectively <xref ref-type="bibr" rid="pbio.1000453-Kouzarides1">[23]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Kundu1">[24]</xref>, both increase and peak at the peri-ovulatory stage <xref ref-type="bibr" rid="pbio.1000453-Kageyama1">[22]</xref>.</p>
<p>After fertilization and the second meiotic division, and between the late 1-cell and 2-cell embryo stages in the mouse, the zygotic genome is activated (ZGA) <xref ref-type="bibr" rid="pbio.1000453-Schultz2">[25]</xref>–<xref ref-type="bibr" rid="pbio.1000453-Li1">[27]</xref>. The maternal and paternal genomes of mouse 1-cell embryos display asymmetric distributions of histone H3 variants as well as di- and tri-methylation of H3K9, H3K4, H3K27, and H3K20, whereas H3K4 and H3K20 monomethylation levels are similar between both pronuclei <xref ref-type="bibr" rid="pbio.1000453-vanderHeijden1">[28]</xref>–<xref ref-type="bibr" rid="pbio.1000453-Sarmento1">[31]</xref>. The asymmetry in H3K9 methylation has been proposed to protect the female pronucleus from global CpG demethylation, which takes place in the paternal pronucleus soon after fertilization <xref ref-type="bibr" rid="pbio.1000453-Lepikhov1">[29]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Santos1">[30]</xref>. In contrast, the significance of the asymmetry of other histone modifications remains unclear.</p>
<p>Histone 3 tail modifications are central to epigenetic regulation, and given the extent of epigenetic reprogramming that takes place during gametogenesis and early development, it is likely that mechanisms regulating H3 methylation play significant roles. However, few functional relationships have been identified. For instance, loss of the H3K27 methyltransferase Enhancer of Zeste 2 (EZH2) causes early post-implantation embryonic lethality <xref ref-type="bibr" rid="pbio.1000453-OCarroll1">[32]</xref>. The absence of maternal EZH2 results in neonatal growth retardation despite the rescue of embryonic lethality by transcription from the paternal allele <xref ref-type="bibr" rid="pbio.1000453-Erhardt1">[33]</xref>. This suggests a role for EZH2 in oogenesis and/or very early development. Furthermore, Embryonic Ectoderm Development (Eed), which is a subunit of the EZH2 H3K27 methyltransferase complex PRC2, is involved in genomic imprinting <xref ref-type="bibr" rid="pbio.1000453-Mager1">[34]</xref>, indicating that EZH2 and H3K27 methylation play, at least, one role in epigenetic reprogramming. In most other cases studied so far, the embryonic lethality caused by loss of an H3 methyltransferase activity has precluded the analysis of how they function in gametogenesis and epigenetic reprogramming.</p>
<p>Tri-methylation of H3K4 marks promoters in all eukaryotes, whereas di-methylation and mono-methylation are associated with transcribed regions and active chromatin <xref ref-type="bibr" rid="pbio.1000453-Kouzarides1">[23]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Jenuwein1">[35]</xref>. In mammals, H3K4 methylation is mediated by at least six enzymes related to fly Trithorax an d the original H3K4 methyltransferase, yeast Set1 <xref ref-type="bibr" rid="pbio.1000453-Roguev1">[36]</xref>. These include MLL1 (Mixed lineage leukemia 1) and MLL2 <xref ref-type="bibr" rid="pbio.1000453-Glaser1">[37]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Milne1">[38]</xref>. Different H3K4 methyltransferases display some overlapping functions; however, they also have unique functional aspects, since MLL1 and MLL2 are both required for development <xref ref-type="bibr" rid="pbio.1000453-Roguev1">[36]</xref>. MLL2 is also required for spermatogenesis, as revealed by ubiquitous conditional mutagenesis in adult males <xref ref-type="bibr" rid="pbio.1000453-Glaser2">[39]</xref>.</p>
<p>Here we report that MLL2 is required for female fertility. Using conditional knockout mutagenesis of <italic>Mll2</italic> in oocytes or ovarian granulosa cells, we found that MLL2 is required for several processes during oocyte postnatal development but is dispensable for granulosa cell function. Surprisingly, we found that MLL2 is essential for bulk H3K4 methylation in peri-ovulatory oocytes, indicating that MLL2 function cannot be compensated by other H3K4 methyltransferases in this cell type. We found that mice with reduced expression of <italic>Mll2</italic> (hypomorph allele, <italic>Mll2<sup>tm2</sup></italic>) showed decreased fertility and a similar, albeit milder phenotype than that of oocyte-specific cKO mice. <italic>Mll2<sup>tm2/tm2</sup></italic> females demonstrate pre-implantation embryonic lethality likely due to impaired ZGA. Our results favor the hypothesis that MLL2 is required during post-natal oogenesis and early preimplantation development, thereby identifying MLL2 as one of the key players in the epigenetic reprogramming required for female fertility in the mouse.</p>
</sec><sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Oocyte and Granulosa Cell-Specific Conditional Knockouts</title>
<p>The epigenome in the female pronucleus of zygotes is established in oocytes <xref ref-type="bibr" rid="pbio.1000453-Lepikhov1">[29]</xref>, under both autonomous and ovarian control <xref ref-type="bibr" rid="pbio.1000453-DeLaFuente3">[14]</xref>. We first evaluated MLL2 expression in ovarian cells and during embryogenesis by PCR analysis. The results show that both ovarian granulosa cells and oocytes from wild type (WT) females express <italic>Mll2</italic> (<xref ref-type="fig" rid="pbio-1000453-g001">Figure 1A</xref>). QPCR analysis of meiotically incompetent (immature) and peri-ovulatory oocytes revealed a 5-fold increase in Mll2 expression as oocytes approach ovulation, suggesting a potential role for MLL2 during fertilization and/or early embryogenesis (<xref ref-type="fig" rid="pbio-1000453-g001">Figure 1B</xref>; <italic>n</italic> = 3; Student's <italic>t</italic> test; <italic>p</italic>&lt;0.05). <italic>Mll2</italic> mRNA was present in 1-cell embryos, likely as a maternal product, and it was expressed from the 2-cell stage to the blastocyst stage as determined by QPCR analysis (<xref ref-type="fig" rid="pbio-1000453-g001">Figure 1C</xref>).</p>
<fig id="pbio-1000453-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000453.g001</object-id><label>Figure 1</label><caption>
<title><italic>Mll2</italic> oocyte-specific deletion mediated by the <italic>Gdf9</italic>-Cre allele leads to female infertility and premature follicle loss.</title>
<p>(A) RT-PCR analysis of <italic>Mll2</italic> showed expression in ovarian granulosa cells (GC) and peri-ovulatory (GV) oocytes (Oo) as determined. (B) Real time PCR (QPCR) analysis of meiotically incompetent (immature) oocytes from 12-d-old females and mature peri-ovulatory (GV, germinal vesicle) oocytes showed a significant increase in <italic>Mll2</italic> mRNA levels towards the peri-ovulatory stage (Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05; three pools of oocytes were used in the analysis; <italic>n</italic> = 3). Results are shown relative to <italic>Mll2</italic> levels in GV oocytes (RQ). <italic>Gapdh</italic> was used as endogenous control. (C) QPCR analysis of preimplantation embryos revealed that <italic>Mll2</italic> is present in 1-cell embryos, likely as a maternal product, and also in subsequent embryonic stages up to the blastocyst (Bl) stage. <italic>Gapdh</italic> was used as endogenous control. Results are shown as arbitrary units (delta CT: CT values corrected by the endogenous control). Abbreviations: GV, germinal vesicle oocytes; 1-C, 1 cell embryos; 2-C, 2 cell embryos; 4-C, 4 cell embryos; M, morula; Bl, blatocyst. (D) cKO mice were generated by tissue-specific deletion of the <italic>Mll2</italic> floxed (“F”) allele in the <italic>Mll2</italic> null allele background. The “F” allele was generated after FLP recombination to remove the stop cassette. Cre recombination eliminates the second exon, thereby causing a frame-shift (“FC” allele). (E) Breeding scheme used to generate <italic>Mll2<sup>Gdf9</sup></italic> cKO mice. (F) <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes show a significant reduction in <italic>Mll2</italic> mRNA levels (Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05). Results are shown as means ± S.E. relative to WT (RQ) (three oocyte pools were used; <italic>n</italic> = 3), and <italic>Gapdh</italic> was used as endogenous control. (G) <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes show negligible levels of MLL2 protein as assessed by Western blot analysis; tubulin was used as loading control. (H) <italic>Mll2<sup>Gdf9</sup></italic> cKO females were infertile; the cumulative number of pups over a 6-mo period is shown (<italic>n</italic> = 10).</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.g001" xlink:type="simple"/></fig>
<p>We used a floxed conditional allele (<italic>Mll2<sup>F</sup></italic>) to dissect MLL2 function (<xref ref-type="fig" rid="pbio-1000453-g001">Figure 1D</xref>). Previous studies with this allele and a tamoxifen-inducible Cre mouse line showed that near-ubiquitous loss of <italic>Mll2</italic> in adult males led to sterility <xref ref-type="bibr" rid="pbio.1000453-Glaser2">[39]</xref>. Here we show that near-ubiquitous loss of <italic>Mll2</italic> in adult females also leads to sterility (<xref ref-type="supplementary-material" rid="pbio.1000453.s001">Figure S1</xref>), further suggesting roles for <italic>Mll2</italic> in gametogenesis. Because <italic>Mll2</italic> is expressed in both granulosa cells and oocytes, we used cell-type specific conditional mutagenesis of the conditional <italic>Mll2</italic> allele. Conditional knockout (cKO) mice were generated using Cre recombinase driven by the growth differentiation factor 9 (<italic>Gdf9</italic>) and zona pellucida (<italic>Zp3</italic>) promoters (<xref ref-type="fig" rid="pbio-1000453-g001">Figure 1E</xref>), which are expressed in oocytes <xref ref-type="bibr" rid="pbio.1000453-Lan1">[40]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Lewandoski1">[41]</xref>) or by the anti-Mullerian hormone receptor 2 (<italic>Amhr2</italic>) promoter, which is expressed primarily in ovarian granulosa cells in adult females <xref ref-type="bibr" rid="pbio.1000453-Jamin1">[42]</xref>. It is noteworthy that expression of <italic>Gdf9-Cre</italic> in the oocyte occurs in all follicular stages from postnatal day 3, whereas expression of <italic>Zp3-Cre</italic> begins at postnatal day 5 from the primary follicular stage onwards <xref ref-type="bibr" rid="pbio.1000453-Lan1">[40]</xref>.</p>
</sec><sec id="s2b">
<title><italic>Mll2</italic> Deletion Mediated by <italic>Gdf9-Cre</italic> Results in Female Sterility and Premature Ovarian Follicle Loss</title>
<p>The effect of Cre recombination on <italic>Mll2</italic> expression in oocytes was examined by QPCR analysis. Oocytes from <italic>Mll2<sup>FC/</sup></italic><sup>−</sup>,<italic>Gdf9-Cre<sup>+</sup></italic> females (herein called <italic>Mll2<sup>Gdf9</sup></italic> cKO) displayed an 80% decrease in <italic>Mll2</italic> mRNA expression compared to WT controls (<xref ref-type="fig" rid="pbio-1000453-g001">Figure 1F</xref>). Cre recombination deletes exon 2 causing a frame-shift and thus no functional protein is produced. Concomitantly, mRNA levels fall presumably due to nonsense mediated decay <xref ref-type="bibr" rid="pbio.1000453-Chang1">[43]</xref>. This was reflected by the presence of negligible levels of protein in isolated peri-ovulatory oocytes from <italic>Mll2<sup>Gdf9</sup></italic> cKO females (<xref ref-type="fig" rid="pbio-1000453-g001">Figure 1F</xref>). Next, by repeated breeding to males of known fertility, we found that <italic>Mll2<sup>Gdf9</sup></italic> cKO females were sterile (<xref ref-type="fig" rid="pbio-1000453-g001">Figure 1G</xref>). To begin to understand the basis of the infertility displayed by <italic>Mll2<sup>Gdf9</sup></italic> cKO mice, we analyzed serum hormone levels. Eight-week-old <italic>Mll2<sup>Gdf9</sup></italic> cKO females displayed increased serum gonadotropin hormones (FSH: WT, 4.24±0.43 ng/ml; <italic>Mll2<sup>Gdf9</sup></italic> cKO, 23.81±1.99 ng/ml; and LH: WT, 0.14±0.03 ng/ml; <italic>Mll2<sup>Gdf9</sup></italic> cKO, 0.87±0.17 ng/ml; <italic>n</italic> = 5; <italic>p</italic>&lt;0.05) and decreased serum estradiol (WT, 21.66±3.2 ng/ml; <italic>Mll2<sup>Gdf9</sup></italic> cKO, 12.24±1.0 ng/ml; <italic>n</italic> = 5; <italic>p</italic> = 0.06), suggesting abnormal folliculogenesis.</p>
<p>To investigate further this potential defect, histological sections of ovaries from <italic>Mll2<sup>Gdf9</sup></italic> cKO females of various ages were evaluated and follicle counts were performed. Based on morphology <xref ref-type="bibr" rid="pbio.1000453-Nilsson1">[44]</xref>, follicles were grouped into three categories: dormant (primordial), growing (primary, secondary, preantral, and antral), or dying (atretic and zona pellucida remnants). Two-week-old <italic>Mll2<sup>Gdf9</sup></italic> cKO ovaries displayed a higher number of primary growing follicles (<xref ref-type="fig" rid="pbio-1000453-g002">Figure 2A and 2B</xref>, upper panels), suggesting increased follicular recruitment. Three-week-old <italic>Mll2<sup>Gdf9</sup></italic> cKO ovaries showed a 50% decrease in dormant follicles and an increase in growing preantral follicles (<xref ref-type="fig" rid="pbio-1000453-g002">Figure 2A and 2B</xref>, middle panels), whereas 8-wk-old <italic>Mll2<sup>Gdf9</sup></italic> cKO ovaries displayed an 80% reduction in dormant follicles (<xref ref-type="fig" rid="pbio-1000453-g002">Figure 2A and 2B</xref>, lower panels), demonstrating increased follicle loss. Further, the number of atretic follicles was significantly increased in <italic>Mll2<sup>Gdf9</sup></italic> cKO females from 3 wk of age onwards (<xref ref-type="fig" rid="pbio-1000453-g002">Figure 2D</xref>; <italic>n</italic> = 5, ANOVA test, <italic>p</italic>&lt;0.05). Older (36-wk-old) <italic>Mll2<sup>Gdf9</sup></italic> cKO ovaries showed few follicles (<xref ref-type="fig" rid="pbio-1000453-g002">Figure 2C</xref>). Together, the results suggest that increased early follicle recruitment and oocyte loss contributes to infertility of <italic>Mll2<sup>Gdf9</sup></italic> females.</p>
<fig id="pbio-1000453-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000453.g002</object-id><label>Figure 2</label><caption>
<title><italic>Mll2<sup>Gdf9</sup></italic> cKO females show increased ovarian follicular recruitment and loss.</title>
<p>(A) PAS-stained ovaries from 2-, 3-, and 8-wk-old mice; the number of follicles was greatly reduced in ovaries from 8-wk-old <italic>Mll2<sup>Gdf9</sup></italic> cKO mice. (B) Follicle counts from 2-, 3-, and 8-wk-old mice. At 2 wk, <italic>Mll2<sup>Gdf9</sup></italic> cKO ovaries showed significantly increased (ANOVA test, * <italic>p</italic>&lt;0.05) primary follicles (Pr), whereas 3-wk-old <italic>Mll2<sup>Gdf9</sup></italic> cKO ovaries showed significantly reduced primordial follicles (Prl) and increased preantral follicles (PA) (ANOVA test, * <italic>p</italic>&lt;0.05). <italic>Mll2<sup>Gdf9</sup></italic> cKO ovaries from 8-wk-old mice showed further reduction in Prl follicles (ANOVA test, * <italic>p</italic>&lt;0.05). Means of follicle counts corrected by surface area ± S.E. are shown (ovarian sections from five individual females were used; <italic>n</italic> = 5). Abbreviations: Prl, primordial; Pr, primary; Sec, secondary; A, antral; CL, corpora lutea. (C) <italic>Mll2<sup>Gdf9</sup></italic> cKO ovaries from 36-wk-old mice stained with hematoxylin-eosin showed very few follicles (boxed area). (D) From 3 wk onwards, the number of atretic follicles was significantly higher in <italic>Mll2<sup>Gdf9</sup></italic> cKO ovaries, compared to controls. Means of follicle counts corrected by surface area ± S.E. are shown (ovarian sections from five individual females were used; <italic>n</italic> = 5). ANOVA test, * <italic>p</italic>&lt;0.05.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.g002" xlink:type="simple"/></fig></sec><sec id="s2c">
<title><italic>Mll2<sup>Gdf9</sup></italic> cKO Females Fail to Ovulate</title>
<p>By stimulation of pre-pubertal mice with gonadotropin hormones to induce ovulation and resumption of meiosis, we found that <italic>Mll2<sup>Gdf9</sup></italic> cKO females were essentially anovulatory (<xref ref-type="fig" rid="pbio-1000453-g003">Figure 3A</xref>; <italic>n</italic> = 4, Student's <italic>t</italic> test, <italic>p</italic>&lt;0.05). Anovulation was confirmed by histologycal analysis of ovaries from hormonally stimulated females, which showed oocytes trapped in luteinizing structures (<xref ref-type="fig" rid="pbio-1000453-g003">Figure 3B</xref>). To determine whether resumption of meiosis was also compromised, we cultured isolated peri-ovulatory oocytes and found that the majority of <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes progressed to meiosis II, whereas a small but significant fraction remained arrested in meiosis I (<xref ref-type="fig" rid="pbio-1000453-g001">Figure 1C and 1D</xref>; ANOVA test; <italic>p</italic>&lt;0.05).</p>
<fig id="pbio-1000453-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000453.g003</object-id><label>Figure 3</label><caption>
<title><italic>Mll2<sup>Gdf9</sup></italic> cKO females show impaired ovulation.</title>
<p>(A) Ovulation rates were significantly reduced in 3-wk-old superovulated <italic>Mll2<sup>Gdf9</sup></italic> cKO females (Student's <italic>t</italic> test, ** <italic>p</italic>&lt;0.01). Means ± S.E. are shown (five individual females were used; <italic>n</italic> = 5). (B) PAS-stained ovaries from superovulated 3-wk-old <italic>Mll2<sup>Gdf9</sup></italic> cKO mice showed trapped oocytes (yellow arrowheads), which correlated with decreased ovulation rates in this mouse line. (C) In vitro oocyte maturation studies; representative single plane confocal laser microscopy micrographs of peri-ovulatory oocytes cultured for 16 h to allow resumption of meiosis; arrows show lagging chromosomes. Magnification: 800×. Abbreviations: MI, meiosis I; MII, meiosis II; PB, polar body. (D) Percentages of meiosis I (MI), meiosis II (MII), or abnormal oocytes after 16 h in culture (ANOVA test, * <italic>p</italic>&lt;0.05). Means ± S.E. of four independent experiments are shown; a total of 120 oocytes per genotype were analyzed.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.g003" xlink:type="simple"/></fig></sec><sec id="s2d">
<title><italic>Mll2<sup>Gdf9</sup></italic> cKO Oocytes Fail to Establish Transcriptional Repression and Show Abnormal Histone Tail Modifications</title>
<p>During folliculogenesis, oocytes acquire a number of epigenetic marks <xref ref-type="bibr" rid="pbio.1000453-Kageyama1">[22]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Ross1">[45]</xref>, undergo large-scale chromatin rearrangement from a non-surrounding (NSN) to a surrounded (SN) nucleolus configuration, and establish a state of global transcriptional repression <xref ref-type="bibr" rid="pbio.1000453-DeLaFuente3">[14]</xref>. Confocal microscopy analysis showed that the percentage of peri-ovulatory oocytes from WT and <italic>Mll2<sup>Gdf9</sup></italic> cKO females that acquired the expected SN configuration <xref ref-type="bibr" rid="pbio.1000453-Zuccotti1">[13]</xref> was comparable (<xref ref-type="fig" rid="pbio-1000453-g004">Figure 4A</xref>). However, using a run-on assay based on Br-UTP incorporation into nascent RNA, we found that, unlike controls, 80% of the <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes were still transcriptionally active at the peri-ovulatory stage (<xref ref-type="fig" rid="pbio-1000453-g004">Figure 4B</xref>, upper and lower panels; Student's <italic>t</italic> test, <italic>p</italic>&lt;0.05). Furthermore, treatment with α-amanitin reduced Br-UTP incorporation <xref ref-type="bibr" rid="pbio.1000453-Levey1">[46]</xref>, indicating that transcription was RNA Pol II-dependent (<xref ref-type="fig" rid="pbio-1000453-g004">Figure 4B</xref>). Hence, our results show that MLL2 is required for oocyte transcriptional silencing and confirm that the establishment of the SN configuration does not depend on the acquisition of global transcriptional repression <xref ref-type="bibr" rid="pbio.1000453-DeLaFuente1">[1]</xref>.</p>
<fig id="pbio-1000453-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000453.g004</object-id><label>Figure 4</label><caption>
<title><italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes fail to establish transcriptional repression.</title>
<p>(A) Confocal laser microscopy analysis of peri-ovulatory oocytes stained with propidium iodide to visualize DNA (upper panel); oocytes were scored as displaying a surrounded nucleolus (SN) or a non-surrounded nucleolus (NSN) configuration (lower panel). Arrows show the nucleolus. No significant differences were observed between controls and <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes (ANOVA test, * <italic>p</italic> = 0.08). Means ± S.E. are shown; a total of 170 oocytes from five individual females were analyzed in three independent experiments. Magnification: 800×. (B) Run-on and confocal microscopy analyses of Br-UTP labeled nascent RNA in peri-ovulatory oocytes. Upper panel: Representative single plane confocal micrographs are shown as merge and split channels (Br-UTP, green staining; and DNA: propidium iodide, red staining). Lower panel: oocytes were scored as positive or negative for Br-UTP staining; note that <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes were transcriptionally active (ANOVA test, * <italic>p</italic>&lt;0.05). Transcription was RNA Pol II dependent as it was abrogated by α-amanitin (αA) (magnification: 800×). Means ± S.E. are shown; a total of 90 oocytes from four individual females were evaluated in three independent experiments.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.g004" xlink:type="simple"/></fig>
<p>Histone tail lysines can be mono-(me1), di-(me2), or tri-(me3) methylated <xref ref-type="bibr" rid="pbio.1000453-Jenuwein1">[35]</xref>. In particular, H3K4me3 is found at the promoters of genes that are transcriptionally active or poised for activity <xref ref-type="bibr" rid="pbio.1000453-Volkel1">[47]</xref>–<xref ref-type="bibr" rid="pbio.1000453-Bernstein2">[50]</xref>. Because MLL2 is a H3K4 histone methyltransferase, we next analyzed the methylation status of H3K4. Confocal microscopy analysis of <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes showed an apparent increase in inmunostaining of H3K4me1 (<xref ref-type="fig" rid="pbio-1000453-g005">Figure 5A</xref>) and a decrease in immunostaining of H3K4me2 and H3K4me3 (<xref ref-type="fig" rid="pbio-1000453-g005">Figure 5B and 5C</xref>), whereas control oocytes displayed the expected distribution of methylation marks (<xref ref-type="fig" rid="pbio-1000453-g005">Figure 5A–C</xref>) <xref ref-type="bibr" rid="pbio.1000453-Arney1">[51]</xref>. Western blot analysis of chromatin fractions followed by chemoluminescence quantification confirmed that <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes have significantly lower levels of H3K4me2 and H3K4me3 and significantly higher levels of H3K4me1 (<xref ref-type="fig" rid="pbio-1000453-g005">Figure 5D and 5E</xref>; Student's <italic>t</italic> test; <italic>p</italic>&lt;0.05). Interestingly, confocal microscopy and Western blot analyses showed that acetylated H4K12, a modification associated with active chromatin <xref ref-type="bibr" rid="pbio.1000453-Kim1">[52]</xref>, was also significantly increased in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes (<xref ref-type="fig" rid="pbio-1000453-g005">Figure 5F–5H</xref>; Student's <italic>t</italic> test; <italic>p</italic>&lt;0.05). In contrast, <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes displayed global levels of repressive marks such as H3K9me3, H3K27me3, and H4K20me1, or those of acetylated H3 that were comparable to those of controls (<xref ref-type="fig" rid="pbio-1000453-g005">Figure 5I</xref>).</p>
<fig id="pbio-1000453-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000453.g005</object-id><label>Figure 5</label><caption>
<title><italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes show loss of bulk H3K4me2 and H3K4me3 as well as H4 hyperacetylation.</title>
<p>(A–C) Confocal microscopy micrographs showing H3K4 methylation levels in peri-ovulatory oocytes. (A) An increase in H3K4me1 is apparent in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes (lower panel) compared to control (upper panel). In contrast, a decrease in H3K4me2 (B) and H3K4me3 (C) levels was observed in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes (B and C, lower panels) compared to controls (B and C, upper panels). Magnification: 800×. Representative single plane micrographs are shown as merge and split channels of histone tail modifications (green) and DNA (red). (D–E) Western blot analysis of H3K4 methylation in chromatin fractions from peri-ovulatory oocytes. (D) Representative micrographs of Western blots showing H3K4me1, H3K4me2, and H3K4me3 levels. (E) Chemoluminescence quantification revealed a significant increase in global H3K4me1 and a significant decrease in global H3K4me2 and H3K4me3 levels in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes; Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05; ** <italic>p</italic>&lt;0.01. Means ± S.E are shown. Three pools of 100 oocytes each from 3–4 females per genotype were used in three independent experiments; samples were normalized against total histones. (F) Confocal microscopy micrographs showing H4K12 acetylation levels in peri-ovulatory oocytes. An increase in H4K12 acetylation is apparent in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes (lower panel) compared to controls (upper panel). Magnification: 800×. Representative single plane micrographs are shown as merge and split channels of histone tail modifications (green) and DNA (red). (G–H) Western blot analysis of H4K12 acetylation (H3K12(ac)) in chromatin fractions from peri-ovulatory oocytes. (G) Representative micrographs of Western blots showing H4K12 acetylation levels. (H) Chemoluminescence quantification revealed a significant increase in global H4K12 acetylation in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes; Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05; Means ± S.E are shown. Three pools of 100 oocytes each from 3–4 females per genotype were used in three independent experiments; samples were normalized against total histones. (I) Western blot analysis of other histone tail modifications in chromatin fractions from peri-ovulatory oocytes. Representative micrographs of Western blots showing H3K9me2, H3K27me3, H4K20me1, and H3(ac); total histones were used as internal loading controls. No changes were observed in the levels of any of the histone tail modifications analyzed. Three pools of 100 oocytes each from 3–4 females per genotype were used in three independent experiments.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.g005" xlink:type="simple"/></fig>
<p>Together, the results suggest that MLL2 is responsible for the majority of maternal H3K4me3 and that other histone methyltransferases cannot compensate MLL2 function in this cell type. Loss of <italic>Mll2</italic> does not affect the establishment/maintenance of other histone post-translational modifications. Importantly, our results show that <italic>Mll2</italic> deficiency leads to a decrease in H3K3me3 but not H3K4me1, suggesting that a histone methyltransferase other than MLL2 is responsible for this methylation mark. The results also indicate that transcriptional repression in peri-ovulatory oocytes is defective in the absence of MLL2. It is unclear whether this phenomenon is a consequence of altered H3K4 methylation, defects in granulosa cell-oocyte communication, or other factors. However, the increased H4K12 acetylation likely reflects the lack of transcriptional silencing observed in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes.</p>
</sec><sec id="s2e">
<title>Abnormal Expression Pro-Apoptotic Genes and <italic>Iap</italic> Elements in <italic>Mll2<sup>Gdf9</sup></italic> cKO Oocytes</title>
<p>Elevated transcription in <italic>Mll2<sup>Gdf9</sup></italic> cKO peri-ovulatory oocytes prompted further investigation of potential gene expression changes. A survey of selected genes involved in oocyte function <xref ref-type="bibr" rid="pbio.1000453-Yu1">[53]</xref>–<xref ref-type="bibr" rid="pbio.1000453-Hutt1">[59]</xref> and early embryogenesis <xref ref-type="bibr" rid="pbio.1000453-Bultman1">[60]</xref>–<xref ref-type="bibr" rid="pbio.1000453-Payer1">[63]</xref> by QPCR analysis of peri-ovulatory oocytes revealed no changes in the majority of genes investigated (<xref ref-type="table" rid="pbio-1000453-t001">Table 1</xref>). An exception was the B-type cyclin E3 ubiquitin ligase cyclin B1 interacting protein 1 (<italic>Ccnb1ip</italic>, also known as <italic>Hei10</italic>), which is important for both meiosis and embryogenesis <xref ref-type="bibr" rid="pbio.1000453-Ward1">[64]</xref>. <italic>Ccnb1ip/Hei10</italic> expression was significantly decreased in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes (<italic>p</italic>&lt;0.05; <xref ref-type="table" rid="pbio-1000453-t001">Table 1</xref>). Interestingly, expression of the histone 4 acetylase <italic>Kat5/Tip60</italic> (Lysine acetyltransferase 5), which has been previously reported to be present in oocytes, was significantly increased in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes (<xref ref-type="table" rid="pbio-1000453-t001">Table 1</xref>, <italic>p</italic>&lt;0.05) <xref ref-type="bibr" rid="pbio.1000453-Oliveri1">[65]</xref> and may therefore contribute to the observed increase in H4K12 acetylation.</p>
<table-wrap id="pbio-1000453-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000453.t001</object-id><label>Table 1</label><caption>
<title>Real time PCR analysis of molecular changes in <italic>Mll2<sup>Gdf9</sup></italic>cKO oocytes.</title>
</caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pbio-1000453-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.t001" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Gene</td>
<td align="left" colspan="1" rowspan="1">Control</td>
<td align="left" colspan="1" rowspan="1">cKO</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Epigenetic factors</bold></td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Mll3</italic></td>
<td align="left" colspan="1" rowspan="1">1.02±0.26</td>
<td align="left" colspan="1" rowspan="1">0.70±0.22</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Setd1a</italic></td>
<td align="left" colspan="1" rowspan="1">1.03±0.28</td>
<td align="left" colspan="1" rowspan="1">1.11±0.17</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Setd8</italic></td>
<td align="left" colspan="1" rowspan="1">1.03±0.16</td>
<td align="left" colspan="1" rowspan="1">1.07±0.15</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Smyd3</italic></td>
<td align="left" colspan="1" rowspan="1">1.06±0.05</td>
<td align="left" colspan="1" rowspan="1">0.87±0.18</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Wdr5</italic></td>
<td align="left" colspan="1" rowspan="1">1.01±0.10</td>
<td align="left" colspan="1" rowspan="1">1.07±0.30</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Ash2l</italic></td>
<td align="left" colspan="1" rowspan="1">1.01±0.11</td>
<td align="left" colspan="1" rowspan="1">1.08±0.30</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Rbbp5</italic></td>
<td align="left" colspan="1" rowspan="1"><bold>0.92±0.04</bold></td>
<td align="left" colspan="1" rowspan="1"><bold>2.27±0.34</bold><xref ref-type="table-fn" rid="nt102">a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Uhrf1</italic></td>
<td align="left" colspan="1" rowspan="1"><bold>0.94±0.07</bold></td>
<td align="left" colspan="1" rowspan="1"><bold>0.43±0.04</bold><xref ref-type="table-fn" rid="nt102">a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Tip60/Kat5</italic></td>
<td align="left" colspan="1" rowspan="1"><bold>1.01±0.07</bold></td>
<td align="left" colspan="1" rowspan="1"><bold>8.53±2.03</bold><xref ref-type="table-fn" rid="nt102">a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Oocyte function and meiosis</bold></td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Gdf9</italic></td>
<td align="left" colspan="1" rowspan="1">1.00±0.12</td>
<td align="left" colspan="1" rowspan="1">1.06±0.18</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Bmp15</italic></td>
<td align="left" colspan="1" rowspan="1">1.69±0.36</td>
<td align="left" colspan="1" rowspan="1">1.43±0.72</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Pten</italic></td>
<td align="left" colspan="1" rowspan="1">1.00±0.10</td>
<td align="left" colspan="1" rowspan="1">1.53±0.35</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Kit</italic></td>
<td align="left" colspan="1" rowspan="1">0.87±0.11</td>
<td align="left" colspan="1" rowspan="1">0.76±0.06</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Yx2</italic></td>
<td align="left" colspan="1" rowspan="1">0.99±0.10</td>
<td align="left" colspan="1" rowspan="1">0.94±0.07</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Pde3a</italic></td>
<td align="left" colspan="1" rowspan="1">0.99±0.11</td>
<td align="left" colspan="1" rowspan="1">1.29±0.51</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Ccnb1ip1</italic></td>
<td align="left" colspan="1" rowspan="1"><bold>1.11±0.12</bold></td>
<td align="left" colspan="1" rowspan="1"><bold>0.04±0.01</bold><xref ref-type="table-fn" rid="nt102">a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Apoptosis/p53</td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Bcl2</italic></td>
<td align="left" colspan="1" rowspan="1">1.02±0.17</td>
<td align="left" colspan="1" rowspan="1">0.91±0.09</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Casp6</italic></td>
<td align="left" colspan="1" rowspan="1"><bold>1.00±0.08</bold></td>
<td align="left" colspan="1" rowspan="1"><bold>1.46±0.04</bold><xref ref-type="table-fn" rid="nt102">a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Bax</italic></td>
<td align="left" colspan="1" rowspan="1"><bold>1.06±0.17</bold></td>
<td align="left" colspan="1" rowspan="1"><bold>1.92±0.18</bold><xref ref-type="table-fn" rid="nt102">a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Cdkn1a/p21</italic></td>
<td align="left" colspan="1" rowspan="1"><bold>1.06±0.06</bold></td>
<td align="left" colspan="1" rowspan="1"><bold>2.07±0.37</bold><xref ref-type="table-fn" rid="nt102">a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Fos</italic></td>
<td align="left" colspan="1" rowspan="1"><bold>1.37±0.43</bold></td>
<td align="left" colspan="1" rowspan="1"><bold>6.29±0.57</bold><xref ref-type="table-fn" rid="nt102">a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Bbc3/Puma</italic></td>
<td align="left" colspan="1" rowspan="1">1.23±0.23</td>
<td align="left" colspan="1" rowspan="1">1.91±0.34</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Setd7</italic></td>
<td align="left" colspan="1" rowspan="1"><bold>1.05±0.07</bold></td>
<td align="left" colspan="1" rowspan="1"><bold>1.87±0.27</bold><xref ref-type="table-fn" rid="nt102">a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>p53</italic></td>
<td align="left" colspan="1" rowspan="1"><bold>1.15±0.10</bold></td>
<td align="left" colspan="1" rowspan="1"><bold>2.12±0.20</bold><xref ref-type="table-fn" rid="nt102">a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Development</bold></td>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1"/>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Nalp5</italic></td>
<td align="left" colspan="1" rowspan="1">1.10±0.47</td>
<td align="left" colspan="1" rowspan="1">1.03±0.50</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Dpp3a</italic></td>
<td align="left" colspan="1" rowspan="1">1.07±0.22</td>
<td align="left" colspan="1" rowspan="1">0.98±0.23</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><italic>Smarca4</italic></td>
<td align="left" colspan="1" rowspan="1">1.07±0.18</td>
<td align="left" colspan="1" rowspan="1">0.85±0.31</td>
</tr>
</tbody>
</table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>Real-time PCR analysis of peri-ovulatory cKO oocytes showed differential expression of genes involved in various biological processes. Results are shown as the mean ± S.E. from three independent oocyte pools (100 oocytes per pool, from 3–4 individual females per genotype). Data were analyzed using the non-parametric Mann-Whitney U test.</p></fn><fn id="nt102"><label>a</label><p><italic>p</italic>&lt;0.05.</p></fn></table-wrap-foot></table-wrap>
<p>QPCR analysis also showed that <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes overexpressed several apoptosis-associated genes (<xref ref-type="table" rid="pbio-1000453-t001">Table 1</xref>), including p53 (transformation related protein 53; TRP53) and <italic>Setd7</italic> (SET domain lysine methyltransferase 7, also know as <italic>Set7/9</italic>) (<xref ref-type="table" rid="pbio-1000453-t001">Table 1</xref> and <xref ref-type="supplementary-material" rid="pbio.1000453.s002">Figure S2A</xref>), which methylates p53 and prevents its degradation <xref ref-type="bibr" rid="pbio.1000453-Chuikov1">[66]</xref>. P53 has been implicated in prenatal oocyte apoptosis, and peri-ovulatory oocytes express low p53 levels <xref ref-type="bibr" rid="pbio.1000453-Ghafari1">[67]</xref>. Consequently, it is possible that up-regulated SETD7 stabilizes p53 in <italic>Mll2<sup>Gdf9</sup></italic>cKO oocytes leading to increased oocyte death. Supporting this hypothesis, we found high levels of p53 protein (<xref ref-type="supplementary-material" rid="pbio.1000453.s002">Figure S2B</xref>) and upregulation of several pro-apoptotic p53 targets, including <italic>Bax</italic> (Bcl2-associated X protein), <italic>Cdkn1a</italic> (cyclin-dependent kinase inhibitor 1A; P21), <italic>Fos</italic> (FBJ murine osteosarcoma viral oncogene homolog) <xref ref-type="bibr" rid="pbio.1000453-Elkeles1">[68]</xref>,<xref ref-type="bibr" rid="pbio.1000453-AndreuVieyra1">[69]</xref>, and <italic>Casp6</italic> (caspase 6) <xref ref-type="bibr" rid="pbio.1000453-MacLachlan1">[70]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Arnault1">[71]</xref> in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes (<xref ref-type="supplementary-material" rid="pbio.1000453.s002">Figure S2C</xref> and <xref ref-type="table" rid="pbio-1000453-t001">Table 1</xref>). Since follicular atresia is thought to occur via apoptosis, the increase in expression of pro-apoptotic factors is in line with the increase in the number of atretic follicles observed in <italic>Mll2<sup>Gdf9</sup></italic> cKO ovaries.</p>
<p>Finally, because of the widespread lack of transcriptional repression in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes, we looked at the expression of retrotransposon interspersed repeats by QPCR analysis. We found that intracisternal A particle (<italic>Iap</italic>) elements were abnormally transcribed in <italic>Mll2<sup>Gdf9</sup></italic> cKO peri-ovulatory oocytes, whereas LINE-1 and SINE-1 elements were not (<xref ref-type="supplementary-material" rid="pbio.1000453.s003">Figure S3A</xref>). Increased <italic>Iap</italic> expression in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes correlated with hypomethylation of <italic>Iap</italic> DNA loci, as evaluated by methylation specific primers (<xref ref-type="supplementary-material" rid="pbio.1000453.s003">Figure S3B</xref>) and bisulphite sequencing (<xref ref-type="supplementary-material" rid="pbio.1000453.s003">Figure S3C</xref>). However, <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes showed a strong signal for 5-methyl-cytosine staining, indicating that loss of CpG methylation was not a widespread phenomenon (<xref ref-type="supplementary-material" rid="pbio.1000453.s003">Figure S3D</xref>). Because retrotransposons drive the expression of multiple host genes in female gametes <xref ref-type="bibr" rid="pbio.1000453-Peaston1">[72]</xref>, <italic>Iap</italic> up-regulation could contribute to loss of <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes. Absence of <italic>Uhrf1</italic> (ubiquitin-like, containing PHD and RING fingers 1 also known Np95) in cell lines and mouse embryos has been associated with increased transcription of interspersed repeats due to DNA hypomethylation <xref ref-type="bibr" rid="pbio.1000453-Sharif1">[73]</xref>. Consequently, we examined <italic>Uhrf1</italic> expression levels and found a 2-fold decrease (<xref ref-type="table" rid="pbio-1000453-t001">Table 1</xref>), suggesting a role in <italic>Iap</italic> deregulation. Decreased <italic>Uhrf1</italic> in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes could also contribute to <italic>Cdkn1a</italic> deregulation <xref ref-type="bibr" rid="pbio.1000453-Kim2">[74]</xref>. Together, the results suggest that stabilization of p53 and abnormal expression of its downstream targets as well as deregulated expression of retrotransposable elements may trigger apoptosis in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes, leading to oocyte death and, ultimately, premature follicle loss and sterility.</p>
</sec><sec id="s2f">
<title>Deletion of <italic>Mll2</italic> Using <italic>Zp3-Cre</italic></title>
<p>To further substantiate the phenotype observed in the <italic>Mll2<sup>Gdf9</sup></italic> cKO mouse model, we employed conditional mutagenesis using the <italic>Zp3-Cre</italic> allele (<xref ref-type="fig" rid="pbio-1000453-g006">Figure 6A</xref>). Peri-ovulatory oocytes from <italic>Mll2<sup>FC/</sup></italic><sup>−</sup>, <italic>Zp3Cre<sup>+</sup></italic> females (herein called <italic>Mll2<sup>Zp3</sup></italic> cKO) show a significant decrease in <italic>Mll2</italic> expression as evaluated by QPCR analysis (<xref ref-type="fig" rid="pbio-1000453-g006">Figure 6B</xref>; Student's <italic>t</italic> test; <italic>p</italic>&lt;0.05; <italic>n</italic> = 3). Similar to <italic>Mll2<sup>Gdf9</sup></italic> cKO mice, <italic>Mll2<sup>Zp3</sup></italic> cKO females showed a significant increase in FSH levels (<xref ref-type="fig" rid="pbio-1000453-g006">Figure 6C</xref>) and were infertile (<xref ref-type="fig" rid="pbio-1000453-g006">Figure 6D</xref>). However, <italic>Mll2<sup>Zp3</sup></italic> cKO females showed a milder rate of follicule loss than that of <italic>Mll2<sup>Gdf9</sup></italic> cKO mice, as evidenced by the lack of significant changes in the number of atretic follicles at 3 wk of age (<xref ref-type="fig" rid="pbio-1000453-g006">Figure 6E and 6F</xref>) and the presenc of follicles at 36 wk of age (<xref ref-type="fig" rid="pbio-1000453-g006">Figure 6E</xref>). In contrast to <italic>Mll2<sup>Gdf9</sup></italic> cKO females, which were anovulatory, <italic>Mll2<sup>Zp3</sup></italic>cKO mice displayed an ovulation rate of 20%–25% compared to controls (<xref ref-type="fig" rid="pbio-1000453-g006">Figure 6G</xref>). Consistent with decreased ovulation rates, <italic>Mll2<sup>Zp3</sup></italic> cKO ovaries showed a number of oocytes trapped in luteinizing structures (<xref ref-type="fig" rid="pbio-1000453-g006">Figure 6H</xref>). Interestingly, oocytes ovulated by <italic>Mll2<sup>Zp3</sup></italic> cKO females were capable of fertilization <italic>in vivo</italic>, and the majority of embryos generated from matings of <italic>Mll2<sup>Zp3</sup></italic> cKO females and WT males became developmentally arrested between the 1-cell and 2-cell stages (<xref ref-type="fig" rid="pbio-1000453-g006">Figure 6I</xref>). Confocal microscopy analysis of <italic>Mll2<sup>Zp3</sup></italic> cKO oocytes showed an increase in the levels of H3K4me1 (<xref ref-type="fig" rid="pbio-1000453-g007">Figure 7A</xref>) and a reduction in the levels of H3K4me3 (<xref ref-type="fig" rid="pbio-1000453-g007">Figure 7B</xref>) comparable to that observed in <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes (<xref ref-type="fig" rid="pbio-1000453-g005">Figure 5A–C</xref>). Western blot analysis confirmed the decrease in bulk H3K4me3 in <italic>Mll2<sup>Zp3</sup></italic>cKO oocytes (<xref ref-type="fig" rid="pbio-1000453-g007">Figure 7C</xref>). These results demonstrate that <italic>Mll2<sup>Zp3</sup></italic> cKO females display a similar but slightly milder phenotype than <italic>Mll2<sup>Gdf9</sup></italic> cKO females, consistent with the later onset of Cre expression in the <italic>Zp3-Cre</italic> line <xref ref-type="bibr" rid="pbio.1000453-Lan1">[40]</xref>. Importantly, the results show that MLL2 is required not only during oogenesis but also for early embryogenesis.</p>
<fig id="pbio-1000453-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000453.g006</object-id><label>Figure 6</label><caption>
<title>Oocyte-specific deletion of <italic>Mll2</italic> mediated by the <italic>Zp3-Cre</italic> allele.</title>
<p>(A) Breeding scheme used to generate <italic>Mll2<sup>Zp3</sup></italic>cKO mice. (B) <italic>Zp3</italic>-cKO oocytes show a significant reduction in <italic>Mll2</italic> mRNA levels (Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05). Results are shown as means ± S.E. relative to WT (RQ) (three oocyte pools were used; <italic>n</italic> = 3) and <italic>Gapdh</italic> was used as endogenous control. (C) FSH levels were significantly higher in serum samples from 8-wk-old <italic>Mll2<sup>Zp3</sup></italic> cKO females compared to controls (Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05; <italic>n</italic> = 10). (D) Fertility studies shown as cumulative number of pups over a 6-mo period. <italic>Mll2<sup>Zp3</sup></italic>cKO females were infertile. (G) Ovulation rates were significantly reduced in <italic>Mll2<sup>Zp3</sup></italic>cKO females compared to controls (WT) (Student's <italic>t</italic> test; * <italic>p</italic>&lt;0.05; <italic>n</italic> = 5). (E) PAS-stained ovaries from 3- and 36-wk-old mice. Original magnification: 25× and 50×; note that different from <italic>Mll2<sup>Gdf9</sup></italic> cKO mice, <italic>Mll2<sup>Zp3</sup></italic> cKO ovaries still contain follicles at 36 wk of age. (F) Follicle counts in <italic>Mll2<sup>Zp3</sup></italic> cKO ovaries. <italic>Mll2<sup>Zp3</sup></italic> cKO ovaries had a significantly lower number of primordial follicles and increased numbers of secondary and multilayer preantral follicles 3 wk of age (left panel). By 8 wk of age (right panel), the number of primordial and multilayer preantral follicles is significantly reduced and the number of atretic follicles is increased in <italic>Mll2<sup>Zp3</sup></italic> cKO ovaries. (ANOVA test; * <italic>p</italic>&lt;0.05; ovarian sections from five females were used in the analysis; <italic>n</italic> = 5). Abbreviations: Prl, primordial; Pr, primary; Sec, secondary; PA, preantral; A, antral; CL, corpora lutea; Atr, atretic. (I) Cultures of embryos from <italic>Mll2<sup>Zp3</sup></italic> cKO females crossed to WT males showed a developmental arrest between the 1-cell and the 4-cell stages. Results are presented as the % embryos (average) ± standard error from five independent experiments. ANOVA test; * <italic>p</italic>&lt;0.05. A total of 95 embryos from six females per genotype were used in three independent experiments. Abbreviations: C, cell; Frag, fragmented; WT, control wild type.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.g006" xlink:type="simple"/></fig><fig id="pbio-1000453-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000453.g007</object-id><label>Figure 7</label><caption>
<title><italic>Mll2<sup>Zp3</sup></italic> cKO oocytes show decreased H3K4 tri-methylation.</title>
<p>(A–B) Confocal microscopy micrographs showing H3K4 methylation levels in peri-ovulatory oocytes. (A) An increase in H3K4me1 is apparent in <italic>Mll2<sup>Zp3</sup></italic> cKO oocytes (lower panel) compared to control (upper panel). In contrast, a decrease in H3K4me3 (B) levels was observed in <italic>Mll2<sup>Zp3</sup></italic> cKO oocytes (lower panel) compared to controls (upper panel). Magnification: 800×. Representative single plane micrographs are shown as merge and split channels of histone tail modifications (green) and DNA (red). (C) Representative micrographs of Western blots showing H3K4me3 levels in chromatin fractions from <italic>Mll2<sup>Zp3</sup></italic> cKO peri-ovulatory oocytes. A decrease in global H3K4me3 is apparent in <italic>Mll2<sup>Zp3</sup></italic>c KO oocytes (Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05). Three pools of 100 oocytes each from 3–4 females per genotype were used in three independent experiments. Total histones were used as internal loading controls.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.g007" xlink:type="simple"/></fig></sec><sec id="s2g">
<title><italic>Mll2</italic> Deletion in Granulosa Cells Has Limited Impact on Female Fertility</title>
<p>To evaluate whether the loss of MLL2 in ovarian granulosa cells affects female fertility, we generated a mouse line carrying a granulosa cell deletion of <italic>Mll2</italic> (<italic>Mll2<sup>FC/</sup></italic><sup>−</sup>, <italic>Amhr2-Cre</italic>, herein called <italic>Mll2<sup>Amhr2</sup></italic> cKO) (<xref ref-type="fig" rid="pbio-1000453-g008">Figure 8A</xref>). In contrast to the oocyte cKOs (<italic>Mll2<sup>Gdf9</sup></italic> cKO and <italic>Mll2<sup>Zp3</sup></italic> cKO), the loss of <italic>Mll2</italic> in granulosa cells had only a small impact on fertility. <italic>Amhr2-Cre</italic> action on <italic>Mll2</italic><sup>F/F</sup> resulted in ∼75% reduction in granulosa cell <italic>Mll2</italic> mRNA levels (<xref ref-type="fig" rid="pbio-1000453-g008">Figure 8B</xref>) and an almost complete loss of protein in <italic>Mll2<sup>Amhr2</sup></italic> cKO granulosa cells as expected from the conditional allele design (<xref ref-type="fig" rid="pbio-1000453-g008">Figure 8C</xref>). In young mice, <italic>Mll2</italic> deficiency in granulosa cells had little impact on fertility (<xref ref-type="fig" rid="pbio-1000453-g008">Figure 8D</xref>), ovulation or fertilization rates (<italic>Mll2<sup>Amhr2</sup></italic>: 45.0±3.1; control: 37.0±2.5, <italic>n</italic> = 4), gonadotropin hormone levels (FSH: control, 6.33±1.39 ng/ml; <italic>Mll2<sup>Amhr2</sup></italic> cKO, 9.51±2.57 ng/ml; LH: control, 0.26±0.07 ng/ml; <italic>Mll2<sup>Amhr2</sup></italic> cKO, 0.17±0.08 ng/ml; <italic>n</italic> = 7), or ovarian histology (unpublished data). However, older animals showed a small reduction in fertility (<xref ref-type="fig" rid="pbio-1000453-g008">Figure 8D</xref>), abnormal ovarian histology, and increased follicle loss (<xref ref-type="fig" rid="pbio-1000453-g008">Figure 8E and 8F</xref>), as evidenced by a significant increase in the number of atretic follicles and a significant decrease in the number of growing follicles (<xref ref-type="fig" rid="pbio-1000453-g008">Figure 8F</xref>; ANOVA test, <italic>p</italic>&lt;0.05). Follicle loss correlated with increased FSH levels in <italic>Mll2<sup>Amhr2</sup></italic> cKO mice (control, 5.31±0.82 ng/ml; <italic>Mll2<sup>Amhr2</sup></italic> cKO, 10.83±0.83 ng/ml; <italic>n</italic> = 7). Analysis of H3K4 methylation levels by Western blot of <italic>Mll2<sup>Amhr2</sup></italic> cKO granulosa cell chromatin fractions showed no changes in the levels of H3K4me1 or H3K4me2 (<xref ref-type="fig" rid="pbio-1000453-g008">Figure 8G and 8H</xref>). A 50% decrease in global H3K4me3 was observed in <italic>Mll2<sup>Amhr2</sup></italic> cKO granulosa cells (<xref ref-type="fig" rid="pbio-1000453-g008">Figure 8G and 8H</xref>; Student's <italic>t</italic> test, <italic>p</italic>&lt;0.05); however, no differences were found in the levels of H3K27me3 between WT and <italic>Mll2<sup>Amhr2</sup></italic> cKO granulosa cells (<xref ref-type="fig" rid="pbio-1000453-g008">Figure 8I</xref>). Finally, QPCR analysis of other H3K4 methyltransferases showed a significant increase in the expression of <italic>Mll3</italic> (WT: 1.46±0.07; <italic>Mll2<sup>Amhr2</sup></italic> cKO: 2.48±0.47; <italic>n</italic> = 3, <italic>p</italic>&lt;0.05) but not <italic>Mll1</italic> (WT: 1.08±0.08; <italic>Mll2<sup>Amhr2</sup></italic> cKO: 1.53±0.47; <italic>n</italic> = 3) in <italic>Mll2<sup>Amhr2</sup></italic> cKO granulosa cells. The results indicate that MLL2 is not essential for granulosa cell function and that an increase in <italic>Mll3</italic> in <italic>Mll2<sup>Amhr2</sup></italic> cKO granulosa cells may, at least partially, compensate for <italic>Mll2</italic> loss.</p>
<fig id="pbio-1000453-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000453.g008</object-id><label>Figure 8</label><caption>
<title>MLL2 is not required for granulosa cell function.</title>
<p>(A) Breeding scheme used to generate granulosa cell-specific cKO mice (<italic>Mll2<sup>Amhr2</sup></italic> cKO). (B) QPCR analysis of <italic>Mll2</italic> levels in granulosa cells from wild type (WT), <italic>Mll2<sup>F/</sup></italic><sup>−</sup> (heterozygous control), and <italic>Mll2<sup>Amhr2</sup></italic> cKO females (granulosa cells from three individual females were used in the analysis; <italic>n</italic> = 3). <italic>Mll2<sup>Amhr2</sup></italic> cKO granulosa cells show a significant decrease in the levels of <italic>Mll2</italic>, whereas <italic>Mll2<sup>F/</sup></italic><sup>−</sup> granulosa cells show the expected 50% decrease in <italic>Mll2</italic> levels (ANOVA test; * <italic>p</italic>&lt;0.05). <italic>Gadpdh</italic> was used as internal control. (C) Western blot analysis of <italic>Mll2<sup>Amhr2</sup></italic> cKO granulosa cells showed decreased MLL2 protein levels. Tubulin was used as loading control. (D) Fertility studies shown as cumulative number of pups over a 6-mo period. <italic>Mll2<sup>Amhr2</sup></italic> cKO females displayed a small reduction in the number of pups (<italic>n</italic> = 10). (E) PAS-stained ovaries from 36-wk-old <italic>Mll2<sup>Amhr2</sup></italic> cKO mice showed PAS-positive zona pellucida remnants (oocyte remnants, arrowheads). Note that the number of follicles present at this age is higher than that observed in the oocyte-specific cKO mouse lines. (F) Follicle counts in 36-wk-old ovaries. <italic>Mll2<sup>Amhr2</sup></italic> cKO ovaries show a significant decrease in the number of quiescent amd growing follicles and a significantly higher number of atretic follicles (ovarian sections from five females were used in this study; <italic>n</italic> = 5). Abbreviations: Prl, primordial; Pr, primary; Sec, secondary; PA, preantral; A, antral; CL, corpora lutea. ANOVA test; <italic>* p</italic>&lt;0.05. (G–H) Western blot analysis of H3K4 methylation in chromatin fractions from granulosa cells. (G) Representative micrographs of Western blots showing H3K4me1, H3K4me2, and H3K4me3 levels. (H) Chemoluminescence quantification revealed a significant decrease in global H3K4me3 levels in <italic>Mll2<sup>Amhr2</sup></italic> cKO granulosa cells (Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05). Means ± S.E are shown. Granulosa cells from three individual females per genotype were used in three independent experiments; samples were normalized against total histones. (G) Representative Western blot analysis of the repressive mark H3K27me3 showed no global changes in <italic>Mll2<sup>Amhr2</sup></italic> cKO granulosa cells. Total histones were used as internal loading control.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.g008" xlink:type="simple"/></fig></sec><sec id="s2h">
<title><italic>Mll2</italic><sup>tm2/tm2</sup> Female Mice Show Reduced Fertility</title>
<p>We generated an <italic>YFP-Mll2</italic> fusion protein by gene targeting in ES cells and name the allele targeted mutation 2 (<italic>Mll2</italic><sup>tm2</sup>; <xref ref-type="supplementary-material" rid="pbio.1000453.s004">Figure S4A</xref>). Homozygous mice carrying the <italic>Mll2</italic><sup>tm2</sup> allele (<italic>Mll2</italic><sup>tm2/tm2</sup>) were viable (<xref ref-type="supplementary-material" rid="pbio.1000453.s004">Figure S4B and S4C</xref>); however, they showed no detectable yellow fluorescent signal in any tissue (unpublished data). To determine whether <italic>YFP-Mll2</italic> was expressed, we analyzed <italic>Mll2</italic><sup>tm2/tm2</sup> ovaries by real-time PCR and Western blot and found a significant decrease in both mRNA (<xref ref-type="supplementary-material" rid="pbio.1000453.s004">Figure S4D</xref>) and protein (<xref ref-type="supplementary-material" rid="pbio.1000453.s004">Figure S4E</xref>) levels, indicating that the mice carrying this allele were hypomorphs for MLL2. We next examined the fertility of <italic>Mll2</italic><sup>tm2/tm2</sup> females by mating them to males of known fertility. From the first month of mating, <italic>Mll2</italic><sup>tm2/tm2</sup> females showed a 50% reduction in the number of pups per litter compared to WT or <italic>Mll2</italic><sup>tm2/+</sup> controls, and showed impaired cumulative fertility with age (<xref ref-type="supplementary-material" rid="pbio.1000453.s004">Figure S4F</xref>). Notably, the fertility of <italic>Mll2</italic><sup>tm2/+</sup> females was also cumulatively reduced (<xref ref-type="supplementary-material" rid="pbio.1000453.s004">Figure S4F</xref>).</p>
</sec><sec id="s2i">
<title>Embryos from <italic>Mll2</italic><sup>tm2/tm2</sup> Females Show Decreased In Vitro Developmental Potential</title>
<p>Ovaries from <italic>Mll2</italic><sup>tm2/tm2</sup> females appeared normal until 4 mo of age (<xref ref-type="supplementary-material" rid="pbio.1000453.s004">Figure S4G</xref>). Unlike the oocyte-specfic cKO mouse lines, ovulation rates of hormonally stimulated pre-pubertal <italic>Mll2</italic><sup>tm2/tm2</sup> and control mice were comparable (<italic>Mll2</italic><sup>tm2/+</sup>: 42.0±3.0; <italic>Mll2</italic><sup>tm2/tm2</sup>:34.0±5; <italic>n</italic> = 4). Furthermore, fertilization rates of young control and <italic>Mll2</italic><sup>tm2/tm2</sup> females were also comparable (WT: 30.0±2.7; <italic>Mll2</italic><sup>tm2/+</sup>: 28.0±2.7; <italic>Mll2</italic><sup>tm2/tm2</sup>: 29.4±3.9; <italic>n</italic> = 12). These findings suggested that subfertility in <italic>Mll2</italic><sup>tm2/tm2</sup> females was due to embryonic defects. In embryo cultures, most embryos from <italic>Mll2</italic><sup>tm2/tm2</sup> intercrosses (75%) arrested between the 1-cell and 4-cell stages whereas &gt;70% of WT embryos developed to the blastocyst stage regardless of the male genotype (<xref ref-type="supplementary-material" rid="pbio.1000453.s004">Figure S4H</xref>). This phenotype was very similar to that of embryos obtained from crossing <italic>Mll2<sup>Zp3</sup></italic>cKO females to WT males. Additionally, a higher percentage of fragmentation (22%), which indicates decreased survival, was observed in <italic>Mll2</italic><sup>tm2/tm2</sup> embryos compared to controls (5%). The severity of this outcome was slightly relieved when <italic>Mll2</italic><sup>tm2/tm2</sup> females were crossed to WT males (<xref ref-type="supplementary-material" rid="pbio.1000453.s004">Figure S4I</xref>), indicating that expression of <italic>Mll2</italic> from the paternal allele could partially rescue the defect. Development was also impaired when <italic>Mll2</italic><sup>tm2/+</sup> females were mated to <italic>Mll2</italic><sup>tm2/tm2</sup> or even WT males (<xref ref-type="supplementary-material" rid="pbio.1000453.s004">Figure S4H and S4I</xref>).</p>
</sec><sec id="s2j">
<title><italic>Mll2</italic><sup>tm2/tm2</sup> Embryos Show Both Reduced ZGA and Bulk H3K4 Methylation</title>
<p>Because the majority of the <italic>Mll2</italic><sup>tm2/tm2</sup> embryos arrested before the 8-cell stage, we evaluated their ability to undergo ZGA using synthesis of the Transcription-Requiring Complex <xref ref-type="bibr" rid="pbio.1000453-Schultz3">[75]</xref> as a marker. Embryos from <italic>Mll2</italic><sup>tm2/tm2</sup> intercrosses showed a 30% reduction in TRC levels compared to controls (<xref ref-type="supplementary-material" rid="pbio.1000453.s005">Figure S5A and S5B</xref>; <italic>n</italic> = 3, <italic>p</italic>&lt;0.05). Therefore, defective ZGA likely contributes to the developmental block observed in <italic>Mll2</italic><sup>tm2/tm2</sup> embryos.</p>
<p>To investigate the potential link between MLL2 activity and ZGA, we analyzed the status of H3K4 methylation in <italic>Mll2</italic><sup>tm2/tm2</sup> embryos. Immunofluorescence and confocal microscopy (<xref ref-type="supplementary-material" rid="pbio.1000453.s006">Figure S6</xref>) showed decreased levels of H3K4me2 and H3K4me3 in female pronuclei of 1-cell embryos from <italic>Mll2</italic><sup>tm2/tm2</sup> intercrosses (<xref ref-type="supplementary-material" rid="pbio.1000453.s006">Figure S6B and S6C</xref>), whereas control embryos showed the expected asymmetry for H3K4 methylation between the female and male pronuclei (<xref ref-type="supplementary-material" rid="pbio.1000453.s006">Figure S6B</xref> abd <xref ref-type="supplementary-material" rid="pbio.1000453.s006">S6C</xref>) <xref ref-type="bibr" rid="pbio.1000453-Sarmento1">[31]</xref>. Western blot analysis of chromatin fractions and chemoluminescence quantification confirmed a significant reduction in H3K4me3 levels in <italic>Mll2</italic><sup>tm2/tm2</sup> zygotes (<xref ref-type="supplementary-material" rid="pbio.1000453.s006">Figure S6</xref>, left and right panels). The results from the hypomorphic allele are in agreement with and extend the results from conditional mutagenesis of <italic>Mll2</italic>. Near-ubiquituous mutagenesis of <italic>Mll2</italic> in female adults caused infertility (<xref ref-type="supplementary-material" rid="pbio.1000453.s001">Figure S1</xref>). Removal of <italic>Mll2</italic> from oocytes but not from granulosa cells also caused infertility. <italic>Gdf9</italic>-cre-mediated deletion of <italic>Mll2</italic> caused a more severe phenotype than <italic>Zp3</italic>-cre-mediated deletion, consistent with the earlier expression of <italic>Gdf9</italic> in oocytes. The hypomorphic allele of <italic>Mll2</italic> presented the mildest phenotype, consistent with a reduction, but not abolishment of MLL2 protein levels (<xref ref-type="supplementary-material" rid="pbio.1000453.s004">Figure S4E</xref>).</p>
</sec></sec><sec id="s3">
<title>Discussion</title>
<p>In this article, we identify MLL2 as one of the major factors controlling bulk H3K4 methylation during oocyte growth and pre-implantation development. Our results indicate that MLL2 is autonomously required in the oocyte for normal oogenesis and pre-implantation development. Oocyte-specific cKO females showed severe defects in fertility, which were also observed in both conditionally mutated and hypomorphic adult females, wheras granulosa cell-specific cKO females showed almost normal fertility. The results suggest differential regulation in H3K4 methylation in gametes and somatic cells. Unlike cKO oocytes (<xref ref-type="table" rid="pbio-1000453-t001">Table 1</xref>), <italic>Mll2<sup>Amhr2</sup></italic> cKO granulosa cells showed an increase in <italic>Mll3</italic>, which could compensate, at least partially, for the loss of <italic>Mll2</italic>.</p>
<p>Our studies demonstrate that MLL2 is required during the transcriptionally active period of oocyte growth for the establishment and/or maintenance of bulk H3K4 tri-methylation (<xref ref-type="fig" rid="pbio-1000453-g009">Figure 9</xref>). A previous study showed that H3K4 methylation increases from immature (meiotically incompetent) oocytes to peri-ovulatory stage (meiotically competent) oocytes <xref ref-type="bibr" rid="pbio.1000453-Kageyama1">[22]</xref>. That study also showed that the expression of the H3K4 methyltransferases <italic>Mll1</italic> and <italic>Smyd3</italic> decreased towards the peri-ovulatory stage, suggesting that a different methyltransferase is responsible for H3K4 methylation in peri-ovulatory oocytes. Here, we show that <italic>Mll2</italic> expression increases towards the peri-ovulatory stage and that its loss in oocytes leads to decreased H3K4 methylation. Our results are consistent with the idea that MLL2 is responsible for the increase in H3K4 methylation in peri-ovulatory oocytes observed by Kageyama and collaborators. In addition, the results suggest that although MLL2 is required throughout oogenesis, MLL2 might be particularly important as oocytes develop meiotic competence.</p>
<fig id="pbio-1000453-g009" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000453.g009</object-id><label>Figure 9</label><caption>
<title>Summary of MLL2 function during gametogenesis and early embryogenesis.</title>
<p>During normal folliculogenesis, oocytes are transcriptionally active and grow in size but do not proliferate. In contrast, the surrounding somatic cells are actively dividing. A number of epigenetic marks are acquired by oocytes during folliculogenesis, including DNA methylation and histone tail modifications. Towards the peri-ovulatory stage, oocytes undergo a large chromatin re-arrangenment into the surrounded nucleolus (SN) configuration and global transcriptional repression (TR). Upon ovulation and fertilization, the maternal pronucleus retains the majority of the histone tail modification marks established in the oocyte, whereas the male pronucleus acquires them progressively. Between the late 1-cell and the 2-cell embryo stages, the maternal mRNA and protein stores are depleted and the zygotic genome is activated (ZGA). MLL2 is expressed in oocytes and during pre-implantation development. <italic>Mll2</italic> oocyte-specific cKO females are infertile due to anovulation and follicle loss. <italic>Mll2-</italic>deficient oocytes show reduced H3K4me3 but not H3K4me1, indicating another enzyme monomethylates H3K4 in oocytes. Oocytes lacking <italic>Mll2</italic> also show abnormal expression of pro-apoptotic genes and Iap elements, which may contribute to oocyte death and, ultimately, follicle loss. Although <italic>Mll2</italic>-deficient oocytes display the SN configuration, they fail to repress transcription, likely due to loss of communication with the granulosa cell compartment. Finally, studies in the hypomorph and the <italic>Mll2<sup>Zp3</sup></italic> cKO model reveal that MLL2 is required either directly or indirectly for embryogenesis and ZGA. Together the results suggest that MLL2 is continuously required during oogenesis and early embryonic development.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.g009" xlink:type="simple"/></fig>
<p>Changes in bulk H3K4me3 methylation (<xref ref-type="fig" rid="pbio-1000453-g005">Figures 5</xref>, <xref ref-type="fig" rid="pbio-1000453-g007">7</xref>, and <xref ref-type="fig" rid="pbio-1000453-g009">9</xref>) observed in oocytes were unexpected because loss of <italic>Mll2</italic> in ES cells or adult mice did not affect bulk H3K4me3 <xref ref-type="bibr" rid="pbio.1000453-Glaser2">[39]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Lubitz1">[76]</xref>. Our findings demonstrate that MLL2 is responsible for the majority of H3K4me3 in oocytes and that a different enzyme(s) is responsible for H3K4me1. Mono-methylation by dedicated monomethylases that co-operate with dedicated di-/tri-methylases has been observed for other histone tail lysines but not for H3K4 <xref ref-type="bibr" rid="pbio.1000453-Jenuwein1">[35]</xref>. Until now, there has been no evidence that a similar mechanism may operate on mammalian H3K4 methylation <xref ref-type="bibr" rid="pbio.1000453-Wu1">[77]</xref>, thereby differing from the paradign H3K4 methyltransferase, yeast Set1C, which mediates mono-, di-, and tri-methylation under the control of its various subunits <xref ref-type="bibr" rid="pbio.1000453-Roguev1">[36]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Shilatifard1">[78]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Dehe1">[79]</xref>.</p>
<p>Oocytes lacking <italic>Mll2</italic> displayed a variety of defects including lack of global transcriptional silencing at the peri-ovulatory stage and abnormal expression of <italic>Uhfr1</italic>, <italic>Ccnblip1</italic>, <italic>Iap</italic>, and pro-apoptotic factors (<xref ref-type="table" rid="pbio-1000453-t001">Table 1</xref> and <xref ref-type="supplementary-material" rid="pbio.1000453.s002">Figures S2</xref>, <xref ref-type="supplementary-material" rid="pbio.1000453.s003">S3</xref>, and 9). The failure to undergo transcriptional silencing is paradoxical because MLL2, like other trithorax-Group factors, acts to maintain expression of target genes <xref ref-type="bibr" rid="pbio.1000453-Glaser2">[39]</xref>. A possible explanation for this paradox is that MLL2 is required for expression of key factors that mediate global transcriptional silencing, and therefore, this defect is likely to be an indirect consequence of <italic>Mll2</italic> loss. Previous studies have shown that granulosa cell-oocyte communication is essential for transcriptional repression in oocytes <xref ref-type="bibr" rid="pbio.1000453-DeLaFuente2">[12]</xref>. Thus, it is possible that altered communication between the gamete and somatic cell compartments in <italic>Mll2<sup>Gdf9</sup></italic> cKO ovaries, as evidenced by the ovulatory defect, may contribute to the lack of transcriptional repression. A previous study showed that global transcriptional silencing occurred without the large chromatin rearrangement into the SN configuration <xref ref-type="bibr" rid="pbio.1000453-DeLaFuente1">[1]</xref>. Here we extend this observation by showing the converse: acquisition of the SN configuration in <italic>Mll2</italic>-deficient oocytes occurred without global transcriptional silencing, confirming that these two events are independent.</p>
<p>It is likely that the observed overexpression of <italic>Iap</italic> elements and apoptotic factors in <italic>Mll2-</italic>deficient oocytes is an indirect consequence of <italic>Mll2</italic> loss. In contrast, the decrease in the expression of <italic>Uhfr1</italic> and <italic>Ccnblip1</italic> may reflect direct regulation of these genes by MLL2, since both genes are expressed from CpG islands, as are all MLL2 targets described to date <xref ref-type="bibr" rid="pbio.1000453-Glaser2">[39]</xref>.</p>
<p>Results in the hypomorph and <italic>Mll2<sup>Zp3</sup></italic> cKO models demonstrated a developmental arrest between the 1- and 4-cell stages, when ZGA takes place in mouse embryos. In addition, <italic>Mll2</italic> hypomorph zygotes displayed impaired ZGA (<xref ref-type="fig" rid="pbio-1000453-g009">Figure 9</xref>). A possible explanation for this phenotype is that unknown maternal factors required for ZGA are lacking in <italic>Mll2</italic>-deficient oocytes. Another possibility is that the establishment of H3K4 di- and tri-methylation in the oocyte by MLL2 contributes to establish a poised starting point for the activation of the embryonic genome after fertilization. Finally, it is also possible that MLL2 itself might be required to activate transcription in the zygote. In this context, we note that MLL2 appears to be continuously required after fertilization during at least the first three cell divisions (<xref ref-type="fig" rid="pbio-1000453-g009">Figure 9</xref>). This conclusion is supported by the fact that MLL2 is expressed in pre-implantation embryos from the 2-cell stage onwards and that embryos derived from <italic>Mll2<sup>Zp3</sup></italic> cKO and <italic>Mll2</italic><sup>tm2/tm2</sup> females undergo developmental arrest. Recently, an unidentified MLL protein has been implicated as part of a BRG-1 containing complex required for ZGA <xref ref-type="bibr" rid="pbio.1000453-Bultman1">[60]</xref>. Our results from the hypomorph model suggest that MLL2 could be this protein.</p>
<p>Finally, recent studies have shown that H3K4 histone methyltransferases, including MLL2, may also play a role in nuclear receptor activation and hormone signaling, at least in human cells <xref ref-type="bibr" rid="pbio.1000453-Ansari1">[80]</xref>. Thus, defective signaling pathways could also contribute to the phenotype observed in the various <italic>Mll2</italic> cKO mouse lines. Undoubtely, more studies are needed to dissect the potential role of MLL2 in those pathways.</p>
<p>Together with previous studies <xref ref-type="bibr" rid="pbio.1000453-Glaser1">[37]</xref>, our findings suggest that during development there is a switch from an MLL2-dependent to MLL2-independent state. In the oocyte, MLL2 is the major tri-H3K4 methyltransferase, and maternal MLL2 is required for the first embryonic divisions. Previous studies showed that <italic>Mll2</italic> KO mice develop up to E9.5 <xref ref-type="bibr" rid="pbio.1000453-Glaser1">[37]</xref>, suggesting that an MLL2-independent state is established after ZGA. We hypothesize that a cell-type specific requirement for MLL2 may be established later in development during gastrulation. This implies a cell-type specific switch in epigenetic roles, which points to a new dimension of complexity in epigenetic regulation.</p>
<p>Our results indicate that MLL2 is required during post-natal oogenesis and the 2–3 embryonic cell divisions, thereby identifying MLL2 as one of the key players in the epigenetic reprogramming required for female fertility in the mouse. Given the recent interest in epigenetics raised by the reprogramming of somatic cells to a pluripotent state equivalent to the epiblast, termed iPS (induced pluripotent stem cells), it will be interesting to determine whether MLL2 is also required for the generation of iPS. If this holds true, MLL2 dependency could be used as a criterion to determine whether reprogramming to iPS cells recapitulates endogenous mechanisms or is largely synthetic short-circuiting.</p>
</sec><sec id="s4" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s4a">
<title>Generation of Mouse Lines</title>
<p>Conditional KO mice were generated by crossing Rosa26CreERT2 <xref ref-type="bibr" rid="pbio.1000453-Seibler1">[81]</xref> <italic>Gdf9-Cre</italic> <xref ref-type="bibr" rid="pbio.1000453-Lan1">[40]</xref>, zona pellucida 3 (<italic>Zp3</italic>)-<italic>Cre</italic> <xref ref-type="bibr" rid="pbio.1000453-Lewandoski1">[41]</xref>, or anti-Mullerian hormone receptor 2 (<italic>Amhr2</italic>)<italic>-Cre</italic> <xref ref-type="bibr" rid="pbio.1000453-Jamin1">[42]</xref> mice and <italic>Mll2</italic><sup>+/−</sup> and <italic>Mll2<sup>F/F</sup></italic> mice <xref ref-type="bibr" rid="pbio.1000453-Glaser1">[37]</xref> as explained in <xref ref-type="supplementary-material" rid="pbio.1000453.s008">Text S1</xref>. The hypomorphic line <italic>Mll2<sup>tm2</sup></italic> was generated inadvertently when a yellow fluorescence protein (YFP) tag was added in frame with the first ATG of <italic>Mll2</italic> located in exon 1 (<xref ref-type="fig" rid="pbio-1000453-g001">Figure 1A</xref>, <xref ref-type="supplementary-material" rid="pbio.1000453.s008">Text S1</xref>). All mouse lines were maintained in the 129/C57BL/6 hybrid background. Genotyping from tail DNA was performed as described <xref ref-type="bibr" rid="pbio.1000453-Glaser1">[37]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Lan1">[40]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Jamin1">[42]</xref>. The decrease in <italic>Mll2</italic> levels was confirmed by quantitative PCR (QPCR) analysis using primers described in <xref ref-type="supplementary-material" rid="pbio.1000453.s007">Table S1</xref>. Mice were maintained in accordance with the NIH Guide for the Care and Use of Laboratory Animals and under German license nr. 24-9168.11-1-2004-26.</p>
</sec><sec id="s4b">
<title>Fertility Studies, Serum Hormone Levels, Histological Analysis, Cell Collection, and Culture</title>
<p>Fertility studies, serum hormone measurements, and histological analysis were performed as previously described <xref ref-type="bibr" rid="pbio.1000453-AndreuVieyra2">[82]</xref>. More details are provided in <xref ref-type="supplementary-material" rid="pbio.1000453.s008">Text S1</xref>. 21-d-old females were injected with 5 IU of pregnant mare serum gonadotropin (PMSG; Calbiochem, EMD, Gibbstown, NJ), and granulosa cells or peri-ovulatory oocytes were collected 47 h later <xref ref-type="bibr" rid="pbio.1000453-AndreuVieyra2">[82]</xref>. Superovulation and ovulation rates in 21-d-old females were carried out as described <xref ref-type="bibr" rid="pbio.1000453-AndreuVieyra2">[82]</xref>. In vitro oocyte maturation and embryo cultures are detailed in <xref ref-type="supplementary-material" rid="pbio.1000453.s008">Text S1</xref>.</p>
</sec><sec id="s4c">
<title>RT-PCR and Quantitative Real Time PCR (QPCR) Analyses</title>
<p>RNA from oocytes or granulosa cells was isolated and subjected to QPCR analysis as described in <xref ref-type="supplementary-material" rid="pbio.1000453.s008">Text S1</xref>. Primer sets are described in <xref ref-type="bibr" rid="pbio.1000453-AndreuVieyra1">[69]</xref> and <xref ref-type="supplementary-material" rid="pbio.1000453.s007">Table S1</xref>. Primer amplification efficiency and transcript levels were calculated as previously described <xref ref-type="bibr" rid="pbio.1000453-AndreuVieyra2">[82]</xref>. <italic>Gapdh</italic> was used as endogenous control. The relative amount of target gene expression for each sample was presented as the mean ± SEM.</p>
</sec><sec id="s4d">
<title>Chromatin Isolation and Western Blot Analysis</title>
<p>Chromatin was isolated from oocytes or granulosa cells without nuclease treatment <xref ref-type="bibr" rid="pbio.1000453-Mendez1">[83]</xref> and equal amounts of protein or equal numbers of oocytes were fractionated in 4%–12% SDS-PAGE Bis-Tris gels (Invitrogen, Carlsbad, CA). Total histones were determined by SYPRO Ruby protein blot stain (Molecular Probes, Invitrogen). Proteins were detected with Super-signal West Pico-detection system (Pierce/Thermo Fisher Scientific, Pittsburgh, PA), and levels were quantified by using the Image J software (NIH). Results are presented as a ratio of modified histone to total histones or protein to tubulin and represent the average of three pools collected in three experiments.</p>
</sec><sec id="s4e">
<title>Immunofluorescence and Confocal Laser-Scanning Microscopy</title>
<p>Peri-ovulatory oocytes were fixed and stained as previously described <xref ref-type="bibr" rid="pbio.1000453-Cowell1">[84]</xref>. Samples were mounted in well-slides (Fisher Scientific) using Vectashield containing propidium iodine (Vector Laboratories, Burlingame, CA). Fluorescence was detected on a laser-scanner confocal microscope (Carl Zeiss, Thornwood, NY). Images were collected at 40× magnification with zoom level equal to 2. For each experimental series, oocytes from all groups were processed under the same conditions and images were captured using the same microscope settings.</p>
</sec><sec id="s4f">
<title>Metabolic Labeling, TRC Complex Detection, Run-On Assays, and DNA Methylation Assays</title>
<p>Metabolic labeling of 2-cell embryos, protein extraction, and TRC detection were performed as previously reported <xref ref-type="bibr" rid="pbio.1000453-Conover1">[85]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Poueymirou1">[86]</xref>. Transcriptional activity was determined in run-on studies after 5-bromo uridine 5′-triphosphate (BrUTP; Sigma) incorporation as previously described <xref ref-type="bibr" rid="pbio.1000453-DeLaFuente2">[12]</xref>,<xref ref-type="bibr" rid="pbio.1000453-Levey1">[46]</xref>. A detailed explanation is presented in <xref ref-type="supplementary-material" rid="pbio.1000453.s008">Text S1</xref>. Global DNA methylation was assessed by immunostaining against 5-methylcytosine, and <italic>Iap</italic> DNA methylation was determined by bisulfite genomic sequencing <xref ref-type="bibr" rid="pbio.1000453-Sharif1">[73]</xref> or bisulphite conversion followed by PCR analysis using methylation-specific primers, which were designed using MethPrimer.</p>
</sec><sec id="s4g">
<title>Data Analysis</title>
<p>Statistical significance was determined by Student's <italic>t</italic> test or one-way analysis of variance (ANOVA) and test for multiple comparison analysis Newman-Keul's (SNK's); <italic>p</italic> values &lt;0.05 were considered to be significant.</p>
</sec></sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pbio.1000453.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.s001" xlink:type="simple"><label>Figure S1</label><caption>
<p><bold>Loss of </bold><bold><italic>Mll2</italic></bold><bold> in adult females using tamoxifen-induced Cre recombination leads to infertility.</bold> <italic>Mll2</italic><sup>F/F</sup>; Rosa26CreERT2/<sup>+</sup> (Mll2<sup>F</sup>, conditional KO, grey bars) or <italic>Mll2</italic><sup>F/+</sup>; Rosa26CreERT2/<sup>+</sup> (control, black bars) females (upper panel) were mated to WT males. Initially ten 2-mo-old adults of each genotype were mated to establish fertility (before induction), then they were treated with tamoxifen as described <xref ref-type="bibr" rid="pbio.1000453-Milne1">[38]</xref> and tested for fertility. The WT males (one male for each pair of tamoxifen treated females) were exchanged every week. Data show the number of successful litters. Note that tamoxifen treatment provokes infertility in females regardless of genotype. After treatment was discontinued, control animals fully recover fertility, whereas <italic>Mll2</italic> conditional KO females remain infertile.</p>
<p>(0.34 MB TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1000453.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.s002" xlink:type="simple"><label>Figure S2</label><caption>
<p><bold><italic>Mll2<sup>Gdf9</sup></italic></bold><bold> cKO oocytes show increased expression of the methyltransferase </bold><bold><italic>Setd7</italic></bold><bold>, p53 stabilization, and expression of p53 downstream pro-apoptotic target genes.</bold> (A) QPCR analysis showed a significant increase in the methyltransferase <italic>Setd7</italic> in <italic>Mll2<sup>Gdf9</sup></italic> cKO peri-ovulatory oocytes (Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05; three pools of oocytes were used in the analysis (<italic>n</italic> = 3)). <italic>Gapdh</italic> was used as endogenous control. (B) Representative Western blot analysis showing increased p53 protein levels in <italic>Mll2<sup>Gdf9</sup></italic> cKO peri-ovulatory oocytes; tubulin was used as loading control. Note that p53 is normally absent in peri-ovulatory stage oocytes. (C) QPCR analysis showed a significant increase in the expression of p53 target genes,which are involved in apoptosis, including <italic>Bax</italic>, <italic>Cdkn1a</italic>, <italic>Fos</italic>, and <italic>Casp6</italic> in <italic>Mll2<sup>Gdf9</sup></italic> cKO peri-ovulatory oocytes (Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05; ** <italic>p</italic>&lt;0.01; three pools of oocytes were used in the analysis (<italic>n</italic> = 3)). <italic>Gapdh</italic> was used as endogenous control.</p>
<p>(0.18 MB TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1000453.s003" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.s003" xlink:type="simple"><label>Figure S3</label><caption>
<p><bold><italic>Mll2<sup>Gdf9</sup></italic></bold><bold> cKO oocytes display abnormal levels of the retrotransposable element Iap.</bold> (A) QPCR analysis of retrotransposon mRNA in isolated peri-ovulatory <italic>Mll2<sup>Gdf9</sup></italic>cKO oocytes showed an increase (Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05) in <italic>Iap</italic> (intracisternal A particle) but not in LINE-1 (Long Interspersed Nuclear Element 1, L1) or SINE-1 (Short Interspersed Nuclear Element); means ± S.E. are shown (three pools of 100 oocytes each were used in the analysis; <italic>n</italic> = 3). (B) Methylation-specific PCR analysis of the <italic>Iap</italic> promoter showed a significant decrease in CpG DNA methylation in peri-ovulatory <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes (Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05); means ± S.E. are shown (three pools of 100 oocytes each were used in the analysis; <italic>n</italic> = 3). (C) Hypomethylation of <italic>Iap</italic> in peri-ovulatory <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes was confirmed by bisulphite sequencing. Methylated and unmethylated CpGs are shown as filled or open circles, respectively. (D) 5-methylcytosine (5-Me-C) staining and confocal microscopy analysis reveal that loss of DNA methylation in peri-ovulatory <italic>Mll2<sup>Gdf9</sup></italic> cKO oocytes is not a widespread phenomenon. Merge and grayscale split channels (5-Me-C, FITC; DNA, propidium iodide, red) of single plane confocal sections are shown. Magnification: 800×.</p>
<p>(0.73 MB TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1000453.s004" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.s004" xlink:type="simple"><label>Figure S4</label><caption>
<p><bold>Generation and characterization of </bold><bold><italic>Mll2</italic></bold><bold><sup>tm2afst/tm2afst</sup> ((</bold><bold><italic>Mll2</italic></bold><bold><sup>tm2/tm2</sup>) mice.</bold> (A) Schematic representation of targeted mutation 2 <italic>Mll2</italic><sup>tm2afst</sup> (denoted throughout as <italic>Mll2</italic><sup>tm2</sup>). An enhanced yellow fluorescence protein (eYFP) cassette was introduced in the N terminus end of <italic>Mll2</italic>, followed by a neomycin (neo) cassette flanked by two Frt (FLP recombination target) sites. FLPe (Flip)-mediated recombination resulted in a continuous reading frame from the authentic <italic>Mll2</italic> initiating codon, through eYFP and the residual FRT to the second amino acid of <italic>Mll2</italic>. (B) Mice carrying a single copy of <italic>Mll2</italic><sup>tm2</sup> (<italic>Mll2</italic><sup>tm2/+</sup>) were intercrossed to obtain control (<italic>Mll2</italic> <sup>+/+</sup>and <italic>Mll2</italic><sup>tm2/+</sup>) and experimental <italic>Mll2</italic><sup>tm2/tm2</sup> mice. (C) Southern blot analysis of tail genomic DNA: a 3.8 kb band denotes the <italic>Mll2</italic><sup>tm2/tm2</sup> allele, whereas a 3.0 kb band denotes the wild type (WT) allele. <italic>Mll2</italic><sup>tm2/+</sup> mice are distinguished by the presence of the two bands. (D) Real time PCR analysis showing a small but significant decrease in <italic>Mll2</italic> mRNA levels in ovaries from <italic>Mll2</italic><sup>tm2/tm2</sup> females (ovaries from three females were used in the analysis (<italic>n</italic> = 3); Student's <italic>t</italic> test, <italic>p</italic>&lt;0.05). (E) Representative Western blot analysis showing a decrease in MLL2 levels in ovaries from <italic>Mll2</italic><sup>tm2/tm2</sup> females; tubulin was used as loading control. (F) Fertility studies shown as cumulative number of pups over a 6-mo period. Females were mated to WT males. The cumulative number of pups produced by <italic>Mll2</italic><sup>tm2/tm2</sup> females was lower than that of controls indicating subfertility (<italic>n</italic> = 10 per genotype). (G) PAS-stained ovaries from 3-wk-old mice. <italic>Mll2</italic><sup>tm2/tm2</sup> ovaries show normal follicular development at this age. Original magnification: 50×. (H,I) Developmental potential of <italic>Mll2</italic><sup>tm2/tm2</sup> embryos. Pre-pubertal (21-d-old) females were superovulated and mated to 6-wk-old <italic>Mll2</italic><sup>tm2/tm2</sup> males, which showed no defects in fertility at this age (H) or WT males (I). Embryonic development was evaluated in vitro. Means ± S.E. from five independent experiments are shown (approximately 35 embryos per each female, from a total of 8–11 females per genotype, were used in the analysis). (H) When females were mated to <italic>Mll2</italic><sup>tm2/tm2</sup> males, a significantly lower percentage of <italic>Mll2</italic><sup>tm2/tm2</sup> embryos reached the blastocyst stage; embryos accumulated between 1C and 4C stages. In contrast, the majority of embryos from WT females developed to blastocysts. (I) When females were mated to WT males, few embryos from <italic>Mll2</italic><sup>tm2/tm2</sup> females reached the blastocyst stage. Abbreviations: 1C, 1-cell; 2C, 2-cell; M, morula; Bl, blastocyst. ANOVA test; * <italic>p</italic>&lt;0.05.</p>
<p>(1.40 MB TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1000453.s005" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.s005" xlink:type="simple"><label>Figure S5</label><caption>
<p><bold><italic>Mll2</italic></bold><bold><sup>tm2/tm2</sup> embryos show defects in zygote genome activation (ZGA).</bold> (A) Representative autoradiogram showing Transcription Required Complex (TRC) complex levels. Two-cell embryos underwent metabolic labeling to determine TRC synthesis, as a marker of ZGA. Note the reduction in TRC levels in <italic>Mll2</italic><sup>tm2/tm2</sup> 2-cell embryos (Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05) in <italic>Mll2</italic><sup>tm2/tm2</sup> 2-cell embryo pools (three pools of embryos from six females per genotype were used in this experiment; <italic>n</italic> = 3); α-amanitin-(α-a)-treated embryos were used as negative controls. (B) Quantification of TRC complex levels. TRC was significantly reduced (Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05) in <italic>Mll2</italic><sup>tm2/tm2</sup> 2-cell embryo pools (three pools of embryos from six females per genotype were used in this experiment; <italic>n</italic> = 3).</p>
<p>(0.15 MB TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1000453.s006" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.s006" xlink:type="simple"><label>Figure S6</label><caption>
<p><bold><italic>Mll2</italic></bold><bold><sup>tm2/tm2</sup> embryos show defects in H3K4 bulk methylation.</bold> (A–C) Representative micrographs showing confocal microscopy analysis of H3K4me1(A), H3K4me2 (B), and H3K4me3 (C); a decrease in H3K4 di- and tri-methylation was observed in the female (f) pronucleus of <italic>Mll2</italic><sup>tm2/tm2</sup> embryos; the male pronucleus (m) is negative for H3K4me2 and H3K4me3, as expected; polar bodies (PB) stain with all antibodies used, as previously reported. Merge and grayscale split channels (H3K3 methylation, FITC; DNA, propidium iodide, red) of single plane confocal sections are shown. (D–E) Western blot analysis of H3K4 methylation in chromatin fractions from zygotes. Three pools of 100 zygotes each from 3–4 females per genotype were used in three independent experiments. Total histones were used as internal loading control. (D) Representative micrographs of Western blots showing H3K4me1 and H3K4me3 levels. (E) Chemoluminescence quantification revealed a significant decrease in global H3K4me3 levels in <italic>Mll2</italic><sup>tm2/tm2</sup> embryos; samples were normalized against total histones. Student's <italic>t</italic> test, * <italic>p</italic>&lt;0.05.</p>
<p>(1.94 MB TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1000453.s007" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.s007" xlink:type="simple"><label>Table S1</label><caption>
<p><bold>List of primer sequences.</bold></p>
<p>(0.05 MB DOC)</p>
</caption></supplementary-material><supplementary-material id="pbio.1000453.s008" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pbio.1000453.s008" xlink:type="simple"><label>Text S1</label><caption>
<p><bold>Supplementary materials and methods.</bold></p>
<p>(0.08 MB DOC)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>The authors wish to thank Dr. A. Cooney (Baylor College of Medicine) for supplying the <italic>Gdf9-Cre</italic> and Dr. R. Behringer (M.D. Anderson) for supplying the <italic>Amhr2-Cre</italic> mouse line, Dr. J. Schaft and Dr. K. Burns for early work on the <italic>Mll2</italic><sup>tm2/tm2</sup> allele mice, and Dr. D. Vieyra for critical reading of the manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pbio.1000453-DeLaFuente1"><label>1</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>De La Fuente</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Viveiros</surname><given-names>M. M</given-names></name>
<name name-style="western"><surname>Burns</surname><given-names>K. H</given-names></name>
<name name-style="western"><surname>Adashi</surname><given-names>E. Y</given-names></name>
<name name-style="western"><surname>Matzuk</surname><given-names>M. M</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Major chromatin remodeling in the germinal vesicle (GV) of mammalian oocytes is dispensable for global transcriptional silencing but required for centromeric heterochromatin function.</article-title>             <source>Dev Biol</source>             <volume>275</volume>             <fpage>447</fpage>             <lpage>458</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Reik1"><label>2</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Reik</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Santos</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Mitsuya</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Morgan</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Dean</surname><given-names>W</given-names></name>
</person-group>             <year>2003</year>             <article-title>Epigenetic asymmetry in the mammalian zygote and early embryo: relationship to lineage commitment?</article-title>             <source>Philos Trans R Soc Lond B Biol Sci</source>             <volume>358</volume>             <fpage>1403</fpage>             <lpage>1409; discussion 1409</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Farthing1"><label>3</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Farthing</surname><given-names>C. R</given-names></name>
<name name-style="western"><surname>Ficz</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Ng</surname><given-names>R. K</given-names></name>
<name name-style="western"><surname>Chan</surname><given-names>C. F</given-names></name>
<name name-style="western"><surname>Andrews</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes.</article-title>             <source>PLoS Genet</source>             <volume>4</volume>             <fpage>e1000116</fpage>             <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pbio.1000116" xlink:type="simple">10.1371/journal.pbio.1000116</ext-link></comment>          </element-citation></ref>
<ref id="pbio.1000453-Silva1"><label>4</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Silva</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Nichols</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Theunissen</surname><given-names>T. W</given-names></name>
<name name-style="western"><surname>Guo</surname><given-names>G</given-names></name>
<name name-style="western"><surname>van Oosten</surname><given-names>A. L</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Nanog is the gateway to the pluripotent ground state.</article-title>             <source>Cell</source>             <volume>138</volume>             <fpage>722</fpage>             <lpage>737</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Nichols1"><label>5</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Nichols</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Smith</surname><given-names>A</given-names></name>
</person-group>             <year>2009</year>             <article-title>Naive and primed pluripotent states.</article-title>             <source>Cell Stem Cell</source>             <volume>4</volume>             <fpage>487</fpage>             <lpage>492</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Matzuk1"><label>6</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Matzuk</surname><given-names>M. M</given-names></name>
<name name-style="western"><surname>Lamb</surname><given-names>D. J</given-names></name>
</person-group>             <year>2002</year>             <article-title>Genetic dissection of mammalian fertility pathways.</article-title>             <source>Nat Cell Biol</source>             <volume>4</volume>             <supplement>Suppl</supplement>             <fpage>s41</fpage>             <lpage>49</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Edson1"><label>7</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Edson</surname><given-names>M. A</given-names></name>
<name name-style="western"><surname>Nagaraja</surname><given-names>A. K</given-names></name>
<name name-style="western"><surname>Matzuk</surname><given-names>M. M</given-names></name>
</person-group>             <year>2009</year>             <article-title>The Mammalian ovary from genesis to revelation.</article-title>             <source>Endocr Rev</source>             <volume>30</volume>             <fpage>624</fpage>             <lpage>712</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Schultz1"><label>8</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Schultz</surname><given-names>R. M</given-names></name>
</person-group>             <year>2002</year>             <article-title>The molecular foundations of the maternal to zygotic transition in the preimplantation embryo.</article-title>             <source>Hum Reprod Update</source>             <volume>8</volume>             <fpage>323</fpage>             <lpage>331</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Liu1"><label>9</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Aoki</surname><given-names>F</given-names></name>
</person-group>             <year>2002</year>             <article-title>Transcriptional activity associated with meiotic competence in fully grown mouse GV oocytes.</article-title>             <source>Zygote</source>             <volume>10</volume>             <fpage>327</fpage>             <lpage>332</lpage>          </element-citation></ref>
<ref id="pbio.1000453-BouniolBaly1"><label>10</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bouniol-Baly</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Hamraoui</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Guibert</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Beaujean</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Szollosi</surname><given-names>M. S</given-names></name>
<etal/></person-group>             <year>1999</year>             <article-title>Differential transcriptional activity associated with chromatin configuration in fully grown mouse germinal vesicle oocytes.</article-title>             <source>Biol Reprod</source>             <volume>60</volume>             <fpage>580</fpage>             <lpage>587</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Debey1"><label>11</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Debey</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Szollosi</surname><given-names>M. S</given-names></name>
<name name-style="western"><surname>Szollosi</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Vautier</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Girousse</surname><given-names>A</given-names></name>
<etal/></person-group>             <year>1993</year>             <article-title>Competent mouse oocytes isolated from antral follicles exhibit different chromatin organization and follow different maturation dynamics.</article-title>             <source>Mol Reprod Dev</source>             <volume>36</volume>             <fpage>59</fpage>             <lpage>74</lpage>          </element-citation></ref>
<ref id="pbio.1000453-DeLaFuente2"><label>12</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>De La Fuente</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Eppig</surname><given-names>J. J</given-names></name>
</person-group>             <year>2001</year>             <article-title>Transcriptional activity of the mouse oocyte genome: companion granulosa cells modulate transcription and chromatin remodeling.</article-title>             <source>Dev Biol</source>             <volume>229</volume>             <fpage>224</fpage>             <lpage>236</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Zuccotti1"><label>13</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Zuccotti</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Ponce</surname><given-names>R. H</given-names></name>
<name name-style="western"><surname>Boiani</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Guizzardi</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Govoni</surname><given-names>P</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>The analysis of chromatin organisation allows selection of mouse antral oocytes competent for development to blastocyst.</article-title>             <source>Zygote</source>             <volume>10</volume>             <fpage>73</fpage>             <lpage>78</lpage>          </element-citation></ref>
<ref id="pbio.1000453-DeLaFuente3"><label>14</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>De La Fuente</surname><given-names>R</given-names></name>
</person-group>             <year>2006</year>             <article-title>Chromatin modifications in the germinal vesicle (GV) of mammalian oocytes.</article-title>             <source>Dev Biol</source>             <volume>292</volume>             <fpage>1</fpage>             <lpage>12</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Schaefer1"><label>15</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Schaefer</surname><given-names>C. B</given-names></name>
<name name-style="western"><surname>Ooi</surname><given-names>S. K</given-names></name>
<name name-style="western"><surname>Bestor</surname><given-names>T. H</given-names></name>
<name name-style="western"><surname>Bourc'his</surname><given-names>D</given-names></name>
</person-group>             <year>2007</year>             <article-title>Epigenetic decisions in mammalian germ cells.</article-title>             <source>Science</source>             <volume>316</volume>             <fpage>398</fpage>             <lpage>399</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Lucifero1"><label>16</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lucifero</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Mertineit</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Clarke</surname><given-names>H. J</given-names></name>
<name name-style="western"><surname>Bestor</surname><given-names>T. H</given-names></name>
<name name-style="western"><surname>Trasler</surname><given-names>J. M</given-names></name>
</person-group>             <year>2002</year>             <article-title>Methylation dynamics of imprinted genes in mouse germ cells.</article-title>             <source>Genomics</source>             <volume>79</volume>             <fpage>530</fpage>             <lpage>538</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Lucifero2"><label>17</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lucifero</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Mann</surname><given-names>M. R</given-names></name>
<name name-style="western"><surname>Bartolomei</surname><given-names>M. S</given-names></name>
<name name-style="western"><surname>Trasler</surname><given-names>J. M</given-names></name>
</person-group>             <year>2004</year>             <article-title>Gene-specific timing and epigenetic memory in oocyte imprinting.</article-title>             <source>Hum Mol Genet</source>             <volume>13</volume>             <fpage>839</fpage>             <lpage>849</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Bourchis1"><label>18</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bourc'his</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Xu</surname><given-names>G. L</given-names></name>
<name name-style="western"><surname>Lin</surname><given-names>C. S</given-names></name>
<name name-style="western"><surname>Bollman</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Bestor</surname><given-names>T. H</given-names></name>
</person-group>             <year>2001</year>             <article-title>Dnmt3L and the establishment of maternal genomic imprints.</article-title>             <source>Science</source>             <volume>294</volume>             <fpage>2536</fpage>             <lpage>2539</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Reik2"><label>19</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Reik</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Dean</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Walter</surname><given-names>J</given-names></name>
</person-group>             <year>2001</year>             <article-title>Epigenetic reprogramming in mammalian development.</article-title>             <source>Science</source>             <volume>293</volume>             <fpage>1089</fpage>             <lpage>1093</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Tanaka1"><label>20</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Tanaka</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Kihara</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Hennebold</surname><given-names>J. D</given-names></name>
<name name-style="western"><surname>Eppig</surname><given-names>J. J</given-names></name>
<name name-style="western"><surname>Viveiros</surname><given-names>M. M</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>H1FOO is coupled to the initiation of oocytic growth.</article-title>             <source>Biol Reprod</source>             <volume>72</volume>             <fpage>135</fpage>             <lpage>142</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Tanaka2"><label>21</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Tanaka</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Kihara</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Meczekalski</surname><given-names>B</given-names></name>
<name name-style="western"><surname>King</surname><given-names>G. J</given-names></name>
<name name-style="western"><surname>Adashi</surname><given-names>E. Y</given-names></name>
</person-group>             <year>2003</year>             <article-title>H1oo: a pre-embryonic H1 linker histone in search of a function.</article-title>             <source>Mol Cell Endocrinol</source>             <volume>202</volume>             <fpage>5</fpage>             <lpage>9</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Kageyama1"><label>22</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kageyama</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Kaneko</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Ooga</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Nagata</surname><given-names>M</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Alterations in epigenetic modifications during oocyte growth in mice.</article-title>             <source>Reproduction</source>             <volume>133</volume>             <fpage>85</fpage>             <lpage>94</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Kouzarides1"><label>23</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kouzarides</surname><given-names>T</given-names></name>
</person-group>             <year>2007</year>             <article-title>Chromatin modifications and their function.</article-title>             <source>Cell</source>             <volume>128</volume>             <fpage>693</fpage>             <lpage>705</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Kundu1"><label>24</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kundu</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Peterson</surname><given-names>C. L</given-names></name>
</person-group>             <year>2009</year>             <article-title>Role of chromatin states in transcriptional memory.</article-title>             <source>Biochim Biophys Acta</source>             <volume>1790</volume>             <fpage>445</fpage>             <lpage>455</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Schultz2"><label>25</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Schultz</surname><given-names>R. M</given-names></name>
<name name-style="western"><surname>Worrad</surname><given-names>D. M</given-names></name>
</person-group>             <year>1995</year>             <article-title>Role of chromatin structure in zygotic gene activation in the mammalian embryo.</article-title>             <source>Semin Cell Biol</source>             <volume>6</volume>             <fpage>201</fpage>             <lpage>208</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Thompson1"><label>26</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Thompson</surname><given-names>E. M</given-names></name>
<name name-style="western"><surname>Legouy</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Renard</surname><given-names>J. P</given-names></name>
</person-group>             <year>1998</year>             <article-title>Mouse embryos do not wait for the MBT: chromatin and RNA polymerase remodeling in genome activation at the onset of development.</article-title>             <source>Dev Genet</source>             <volume>22</volume>             <fpage>31</fpage>             <lpage>42</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Li1"><label>27</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Li</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Zheng</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Dean</surname><given-names>J</given-names></name>
</person-group>             <year>2010</year>             <article-title>Maternal control of early mouse development.</article-title>             <source>Development</source>             <volume>137</volume>             <fpage>859</fpage>             <lpage>870</lpage>          </element-citation></ref>
<ref id="pbio.1000453-vanderHeijden1"><label>28</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>van der Heijden</surname><given-names>G. W</given-names></name>
<name name-style="western"><surname>Dieker</surname><given-names>J. W</given-names></name>
<name name-style="western"><surname>Derijck</surname><given-names>A. A</given-names></name>
<name name-style="western"><surname>Muller</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Berden</surname><given-names>J. H</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Asymmetry in histone H3 variants and lysine methylation between paternal and maternal chromatin of the early mouse zygote.</article-title>             <source>Mech Dev</source>             <volume>122</volume>             <fpage>1008</fpage>             <lpage>1022</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Lepikhov1"><label>29</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lepikhov</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Walter</surname><given-names>J</given-names></name>
</person-group>             <year>2004</year>             <article-title>Differential dynamics of histone H3 methylation at positions K4 and K9 in the mouse zygote.</article-title>             <source>BMC Dev Biol</source>             <volume>4</volume>             <fpage>12</fpage>          </element-citation></ref>
<ref id="pbio.1000453-Santos1"><label>30</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Santos</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Hendrich</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Reik</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Dean</surname><given-names>W</given-names></name>
</person-group>             <year>2002</year>             <article-title>Dynamic reprogramming of DNA methylation in the early mouse embryo.</article-title>             <source>Dev Biol</source>             <volume>241</volume>             <fpage>172</fpage>             <lpage>182</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Sarmento1"><label>31</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Sarmento</surname><given-names>O. F</given-names></name>
<name name-style="western"><surname>Digilio</surname><given-names>L. C</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Perlin</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Herr</surname><given-names>J. C</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Dynamic alterations of specific histone modifications during early murine development.</article-title>             <source>J Cell Sci</source>             <volume>117</volume>             <fpage>4449</fpage>             <lpage>4459</lpage>          </element-citation></ref>
<ref id="pbio.1000453-OCarroll1"><label>32</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>O'Carroll</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Erhardt</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Pagani</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Barton</surname><given-names>S. C</given-names></name>
<name name-style="western"><surname>Surani</surname><given-names>M. A</given-names></name>
<etal/></person-group>             <year>2001</year>             <article-title>The polycomb-group gene Ezh2 is required for early mouse development.</article-title>             <source>Mol Cell Biol</source>             <volume>21</volume>             <fpage>4330</fpage>             <lpage>4336</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Erhardt1"><label>33</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Erhardt</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Su</surname><given-names>I. H</given-names></name>
<name name-style="western"><surname>Schneider</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Barton</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Bannister</surname><given-names>A. J</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Consequences of the depletion of zygotic and embryonic enhancer of zeste 2 during preimplantation mouse development.</article-title>             <source>Development</source>             <volume>130</volume>             <fpage>4235</fpage>             <lpage>4248</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Mager1"><label>34</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Mager</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Montgomery</surname><given-names>N. D</given-names></name>
<name name-style="western"><surname>de Villena</surname><given-names>F. P</given-names></name>
<name name-style="western"><surname>Magnuson</surname><given-names>T</given-names></name>
</person-group>             <year>2003</year>             <article-title>Genome imprinting regulated by the mouse Polycomb group protein Eed.</article-title>             <source>Nat Genet</source>             <volume>33</volume>             <fpage>502</fpage>             <lpage>507</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Jenuwein1"><label>35</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Jenuwein</surname><given-names>T</given-names></name>
</person-group>             <year>2006</year>             <article-title>The epigenetic magic of histone lysine methylation.</article-title>             <source>Febs J</source>             <volume>273</volume>             <fpage>3121</fpage>             <lpage>3135</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Roguev1"><label>36</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Roguev</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Schaft</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Shevchenko</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Pijnappel</surname><given-names>W. W</given-names></name>
<name name-style="western"><surname>Wilm</surname><given-names>M</given-names></name>
<etal/></person-group>             <year>2001</year>             <article-title>The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue and methylates histone 3 lysine 4.</article-title>             <source>Embo J</source>             <volume>20</volume>             <fpage>7137</fpage>             <lpage>7148</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Glaser1"><label>37</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Glaser</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Schaft</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Lubitz</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Vintersten</surname><given-names>K</given-names></name>
<name name-style="western"><surname>van der Hoeven</surname><given-names>F</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Multiple epigenetic maintenance factors implicated by the loss of Mll2 in mouse development.</article-title>             <source>Development</source>             <volume>133</volume>             <fpage>1423</fpage>             <lpage>1432</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Milne1"><label>38</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Milne</surname><given-names>T. A</given-names></name>
<name name-style="western"><surname>Briggs</surname><given-names>S. D</given-names></name>
<name name-style="western"><surname>Brock</surname><given-names>H. W</given-names></name>
<name name-style="western"><surname>Martin</surname><given-names>M. E</given-names></name>
<name name-style="western"><surname>Gibbs</surname><given-names>D</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>MLL targets SET domain methyltransferase activity to Hox gene promoters.</article-title>             <source>Mol Cell</source>             <volume>10</volume>             <fpage>1107</fpage>             <lpage>1117</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Glaser2"><label>39</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Glaser</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Lubitz</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Loveland</surname><given-names>K. L</given-names></name>
<name name-style="western"><surname>Ohbo</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Robb</surname><given-names>L</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>The histone 3 lysine 4 methyltransferase, Mll2, is only required briefly in development and spermatogenesis.</article-title>             <source>Epigenetics Chromatin</source>             <volume>2</volume>             <fpage>5</fpage>          </element-citation></ref>
<ref id="pbio.1000453-Lan1"><label>40</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lan</surname><given-names>Z. J</given-names></name>
<name name-style="western"><surname>Xu</surname><given-names>X</given-names></name>
<name name-style="western"><surname>Cooney</surname><given-names>A. J</given-names></name>
</person-group>             <year>2004</year>             <article-title>Differential oocyte-specific expression of Cre recombinase activity in GDF-9-iCre, Zp3cre, and Msx2Cre transgenic mice.</article-title>             <source>Biol Reprod</source>             <volume>71</volume>             <fpage>1469</fpage>             <lpage>1474</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Lewandoski1"><label>41</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lewandoski</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Wassarman</surname><given-names>K. M</given-names></name>
<name name-style="western"><surname>Martin</surname><given-names>G. R</given-names></name>
</person-group>             <year>1997</year>             <article-title>Zp3-cre, a transgenic mouse line for the activation or inactivation of loxP-flanked target genes specifically in the female germ line.</article-title>             <source>Curr Biol</source>             <volume>7</volume>             <fpage>148</fpage>             <lpage>151</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Jamin1"><label>42</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Jamin</surname><given-names>S. P</given-names></name>
<name name-style="western"><surname>Arango</surname><given-names>N. A</given-names></name>
<name name-style="western"><surname>Mishina</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Hanks</surname><given-names>M. C</given-names></name>
<name name-style="western"><surname>Behringer</surname><given-names>R. R</given-names></name>
</person-group>             <year>2003</year>             <article-title>Genetic studies of the AMH/MIS signaling pathway for Mullerian duct regression.</article-title>             <source>Mol Cell Endocrinol</source>             <volume>211</volume>             <fpage>15</fpage>             <lpage>19</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Chang1"><label>43</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Chang</surname><given-names>Y. F</given-names></name>
<name name-style="western"><surname>Imam</surname><given-names>J. S</given-names></name>
<name name-style="western"><surname>Wilkinson</surname><given-names>M. F</given-names></name>
</person-group>             <year>2007</year>             <article-title>The nonsense-mediated decay RNA surveillance pathway.</article-title>             <source>Annu Rev Biochem</source>             <volume>76</volume>             <fpage>51</fpage>             <lpage>74</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Nilsson1"><label>44</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Nilsson</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Skinner</surname><given-names>M. K</given-names></name>
</person-group>             <year>2001</year>             <article-title>Cellular interactions that control primordial follicle development and folliculogenesis.</article-title>             <source>J Soc Gynecol Investig</source>             <volume>8</volume>             <fpage>S17</fpage>             <lpage>20</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Ross1"><label>45</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ross</surname><given-names>P. J</given-names></name>
<name name-style="western"><surname>Ragina</surname><given-names>N. P</given-names></name>
<name name-style="western"><surname>Rodriguez</surname><given-names>R. M</given-names></name>
<name name-style="western"><surname>Iager</surname><given-names>A. E</given-names></name>
<name name-style="western"><surname>Siripattarapravat</surname><given-names>K</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Polycomb gene expression and histone H3 lysine 27 trimethylation changes during bovine preimplantation development.</article-title>             <source>Reproduction</source>             <volume>136</volume>             <fpage>777</fpage>             <lpage>785</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Levey1"><label>46</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Levey</surname><given-names>I. L</given-names></name>
<name name-style="western"><surname>Brinster</surname><given-names>R. L</given-names></name>
</person-group>             <year>1978</year>             <article-title>Effects of alpha-amanitin on RNA synthesis by mouse embryos in culture.</article-title>             <source>J Exp Zool</source>             <volume>203</volume>             <fpage>351</fpage>             <lpage>360</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Volkel1"><label>47</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Volkel</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Angrand</surname><given-names>P. O</given-names></name>
</person-group>             <year>2007</year>             <article-title>The control of histone lysine methylation in epigenetic regulation.</article-title>             <source>Biochimie</source>             <volume>89</volume>             <fpage>1</fpage>             <lpage>20</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Ruthenburg1"><label>48</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ruthenburg</surname><given-names>A. J</given-names></name>
<name name-style="western"><surname>Allis</surname><given-names>C. D</given-names></name>
<name name-style="western"><surname>Wysocka</surname><given-names>J</given-names></name>
</person-group>             <year>2007</year>             <article-title>Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark.</article-title>             <source>Mol Cell</source>             <volume>25</volume>             <fpage>15</fpage>             <lpage>30</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Bernstein1"><label>49</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bernstein</surname><given-names>B. E</given-names></name>
<name name-style="western"><surname>Mikkelsen</surname><given-names>T. S</given-names></name>
<name name-style="western"><surname>Xie</surname><given-names>X</given-names></name>
<name name-style="western"><surname>Kamal</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Huebert</surname><given-names>D. J</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>A bivalent chromatin structure marks key developmental genes in embryonic stem cells.</article-title>             <source>Cell</source>             <volume>125</volume>             <fpage>315</fpage>             <lpage>326</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Bernstein2"><label>50</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bernstein</surname><given-names>B. E</given-names></name>
<name name-style="western"><surname>Kamal</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Lindblad-Toh</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Bekiranov</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Bailey</surname><given-names>D. K</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Genomic maps and comparative analysis of histone modifications in human and mouse.</article-title>             <source>Cell</source>             <volume>120</volume>             <fpage>169</fpage>             <lpage>181</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Arney1"><label>51</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Arney</surname><given-names>K. L</given-names></name>
<name name-style="western"><surname>Bao</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Bannister</surname><given-names>A. J</given-names></name>
<name name-style="western"><surname>Kouzarides</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Surani</surname><given-names>M. A</given-names></name>
</person-group>             <year>2002</year>             <article-title>Histone methylation defines epigenetic asymmetry in the mouse zygote.</article-title>             <source>Int J Dev Biol</source>             <volume>46</volume>             <fpage>317</fpage>             <lpage>320</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Kim1"><label>52</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kim</surname><given-names>J. M</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Tazaki</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Nagata</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Aoki</surname><given-names>F</given-names></name>
</person-group>             <year>2003</year>             <article-title>Changes in histone acetylation during mouse oocyte meiosis.</article-title>             <source>J Cell Biol</source>             <volume>162</volume>             <fpage>37</fpage>             <lpage>46</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Yu1"><label>53</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Yu</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Deng</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Medvedev</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Hecht</surname><given-names>N. B</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Transgenic RNAi-mediated reduction of MSY2 in mouse oocytes results in reduced fertility.</article-title>             <source>Dev Biol</source>             <volume>268</volume>             <fpage>195</fpage>             <lpage>206</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Zheng1"><label>54</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Zheng</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Dean</surname><given-names>J</given-names></name>
</person-group>             <year>2007</year>             <article-title>Oocyte-specific genes affect folliculogenesis, fertilization, and early development.</article-title>             <source>Semin Reprod Med</source>             <volume>25</volume>             <fpage>243</fpage>             <lpage>251</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Ye1"><label>55</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ye</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Kawamura</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Sasaki</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Kawamura</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Groenen</surname><given-names>P</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Kit ligand promotes first polar body extrusion of mouse preovulatory oocytes.</article-title>             <source>Reprod Biol Endocrinol</source>             <volume>7</volume>             <fpage>26</fpage>          </element-citation></ref>
<ref id="pbio.1000453-Reddy1"><label>56</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Reddy</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Adhikari</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Jagarlamudi</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Rajareddy</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool.</article-title>             <source>Science</source>             <volume>319</volume>             <fpage>611</fpage>             <lpage>613</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Masciarelli1"><label>57</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Masciarelli</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Horner</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Park</surname><given-names>S. H</given-names></name>
<name name-style="western"><surname>Hinckley</surname><given-names>M</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Cyclic nucleotide phosphodiesterase 3A-deficient mice as a model of female infertility.</article-title>             <source>J Clin Invest</source>             <volume>114</volume>             <fpage>196</fpage>             <lpage>205</lpage>          </element-citation></ref>
<ref id="pbio.1000453-McMahon1"><label>58</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>McMahon</surname><given-names>H. E</given-names></name>
<name name-style="western"><surname>Hashimoto</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Mellon</surname><given-names>P. L</given-names></name>
<name name-style="western"><surname>Shimasaki</surname><given-names>S</given-names></name>
</person-group>             <year>2008</year>             <article-title>Oocyte-specific overexpression of mouse bone morphogenetic protein-15 leads to accelerated folliculogenesis and an early onset of acyclicity in transgenic mice.</article-title>             <source>Endocrinology</source>             <volume>149</volume>             <fpage>2807</fpage>             <lpage>2815</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Hutt1"><label>59</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hutt</surname><given-names>K. J</given-names></name>
<name name-style="western"><surname>McLaughlin</surname><given-names>E. A</given-names></name>
<name name-style="western"><surname>Holland</surname><given-names>M. K</given-names></name>
</person-group>             <year>2006</year>             <article-title>KIT/KIT ligand in mammalian oogenesis and folliculogenesis: roles in rabbit and murine ovarian follicle activation and oocyte growth.</article-title>             <source>Biol Reprod</source>             <volume>75</volume>             <fpage>421</fpage>             <lpage>433</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Bultman1"><label>60</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bultman</surname><given-names>S. J</given-names></name>
<name name-style="western"><surname>Gebuhr</surname><given-names>T. C</given-names></name>
<name name-style="western"><surname>Pan</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Svoboda</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Schultz</surname><given-names>R. M</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Maternal BRG1 regulates zygotic genome activation in the mouse.</article-title>             <source>Genes Dev</source>             <volume>20</volume>             <fpage>1744</fpage>             <lpage>1754</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Tong1"><label>61</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Tong</surname><given-names>Z. B</given-names></name>
<name name-style="western"><surname>Gold</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Pfeifer</surname><given-names>K. E</given-names></name>
<name name-style="western"><surname>Dorward</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Lee</surname><given-names>E</given-names></name>
<etal/></person-group>             <year>2000</year>             <article-title>Mater, a maternal effect gene required for early embryonic development in mice.</article-title>             <source>Nat Genet</source>             <volume>26</volume>             <fpage>267</fpage>             <lpage>268</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Oda1"><label>62</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Oda</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Okamoto</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Murphy</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Chu</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Price</surname><given-names>S. M</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Monomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development.</article-title>             <source>Mol Cell Biol</source>             <volume>29</volume>             <fpage>2278</fpage>             <lpage>2295</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Payer1"><label>63</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Payer</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Saitou</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Barton</surname><given-names>S. C</given-names></name>
<name name-style="western"><surname>Thresher</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Dixon</surname><given-names>J. P</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Stella is a maternal effect gene required for normal early development in mice.</article-title>             <source>Curr Biol</source>             <volume>13</volume>             <fpage>2110</fpage>             <lpage>2117</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Ward1"><label>64</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ward</surname><given-names>J. O</given-names></name>
<name name-style="western"><surname>Reinholdt</surname><given-names>L. G</given-names></name>
<name name-style="western"><surname>Motley</surname><given-names>W. W</given-names></name>
<name name-style="western"><surname>Niswander</surname><given-names>L. M</given-names></name>
<name name-style="western"><surname>Deacon</surname><given-names>D. C</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Mutation in mouse hei10, an e3 ubiquitin ligase, disrupts meiotic crossing over.</article-title>             <source>PLoS Genet</source>             <volume>3</volume>             <fpage>e139</fpage>             <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.0030139" xlink:type="simple">10.1371/journal.pgen.0030139</ext-link></comment>          </element-citation></ref>
<ref id="pbio.1000453-Oliveri1"><label>65</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Oliveri</surname><given-names>R. S</given-names></name>
<name name-style="western"><surname>Kalisz</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Schjerling</surname><given-names>C. K</given-names></name>
<name name-style="western"><surname>Andersen</surname><given-names>C. Y</given-names></name>
<name name-style="western"><surname>Borup</surname><given-names>R</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Evaluation in mammalian oocytes of gene transcripts linked to epigenetic reprogramming.</article-title>             <source>Reproduction</source>             <volume>134</volume>             <fpage>549</fpage>             <lpage>558</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Chuikov1"><label>66</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Chuikov</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Kurash</surname><given-names>J. K</given-names></name>
<name name-style="western"><surname>Wilson</surname><given-names>J. R</given-names></name>
<name name-style="western"><surname>Xiao</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Justin</surname><given-names>N</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Regulation of p53 activity through lysine methylation.</article-title>             <source>Nature</source>             <volume>432</volume>             <fpage>353</fpage>             <lpage>360</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Ghafari1"><label>67</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ghafari</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Pelengaris</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Walters</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Hartshorne</surname><given-names>G. M</given-names></name>
</person-group>             <year>2009</year>             <article-title>Influence of p53 and genetic background on prenatal oogenesis and oocyte attrition in mice.</article-title>             <source>Hum Reprod</source>             <volume>24</volume>             <fpage>1460</fpage>             <lpage>1472</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Elkeles1"><label>68</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Elkeles</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Juven-Gershon</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Israeli</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Wilder</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Zalcenstein</surname><given-names>A</given-names></name>
<etal/></person-group>             <year>1999</year>             <article-title>The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor.</article-title>             <source>Mol Cell Biol</source>             <volume>19</volume>             <fpage>2594</fpage>             <lpage>2600</lpage>          </element-citation></ref>
<ref id="pbio.1000453-AndreuVieyra1"><label>69</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Andreu-Vieyra</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Chen</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Matzuk</surname><given-names>M. M</given-names></name>
</person-group>             <year>2007</year>             <article-title>Effects of granulosa cell-specific deletion of Rb in Inha-alpha null female mice.</article-title>             <source>Endocrinology</source>             <volume>148</volume>             <fpage>3837</fpage>             <lpage>3849</lpage>          </element-citation></ref>
<ref id="pbio.1000453-MacLachlan1"><label>70</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>MacLachlan</surname><given-names>T. K</given-names></name>
<name name-style="western"><surname>El-Deiry</surname><given-names>W. S</given-names></name>
</person-group>             <year>2002</year>             <article-title>Apoptotic threshold is lowered by p53 transactivation of caspase-6.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>99</volume>             <fpage>9492</fpage>             <lpage>9497</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Arnault1"><label>71</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Arnault</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Doussau</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Pesty</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Lefevre</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Courtot</surname></name>
</person-group>             <year>2010</year>             <article-title>AM Review: Lamin A/C, caspase-6, and chromatin configuration during meiosis resumption in the mouse oocyte.</article-title>             <source>Reprod Sci</source>             <volume>17</volume>             <fpage>102</fpage>             <lpage>115</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Peaston1"><label>72</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Peaston</surname><given-names>A. E</given-names></name>
<name name-style="western"><surname>Evsikov</surname><given-names>A. V</given-names></name>
<name name-style="western"><surname>Graber</surname><given-names>J. H</given-names></name>
<name name-style="western"><surname>de Vries</surname><given-names>W. N</given-names></name>
<name name-style="western"><surname>Holbrook</surname><given-names>A. E</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Retrotransposons regulate host genes in mouse oocytes and preimplantation embryos.</article-title>             <source>Dev Cell</source>             <volume>7</volume>             <fpage>597</fpage>             <lpage>606</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Sharif1"><label>73</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Sharif</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Muto</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Takebayashi</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Suetake</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Iwamatsu</surname><given-names>A</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA.</article-title>             <source>Nature</source>             <volume>450</volume>             <fpage>908</fpage>             <lpage>912</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Kim2"><label>74</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kim</surname><given-names>J. K</given-names></name>
<name name-style="western"><surname>Esteve</surname><given-names>P. O</given-names></name>
<name name-style="western"><surname>Jacobsen</surname><given-names>S. E</given-names></name>
<name name-style="western"><surname>Pradhan</surname><given-names>S</given-names></name>
</person-group>             <year>2009</year>             <article-title>UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells.</article-title>             <source>Nucleic Acids Res</source>             <volume>37</volume>             <fpage>493</fpage>             <lpage>505</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Schultz3"><label>75</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Schultz</surname><given-names>R. M</given-names></name>
</person-group>             <year>1993</year>             <article-title>Regulation of zygotic gene activation in the mouse.</article-title>             <source>Bioessays</source>             <volume>15</volume>             <fpage>531</fpage>             <lpage>538</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Lubitz1"><label>76</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lubitz</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Glaser</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Schaft</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Stewart</surname><given-names>A. F</given-names></name>
<name name-style="western"><surname>Anastassiadis</surname><given-names>K</given-names></name>
</person-group>             <year>2007</year>             <article-title>Increased apoptosis and skewed differentiation in mouse embryonic stem cells lacking the histone methyltransferase Mll2.</article-title>             <source>Mol Biol Cell</source>             <volume>18</volume>             <fpage>2356</fpage>             <lpage>2366</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Wu1"><label>77</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wu</surname><given-names>X</given-names></name>
<name name-style="western"><surname>Hua</surname><given-names>X</given-names></name>
</person-group>             <year>2008</year>             <article-title>Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.</article-title>             <source>Curr Mol Med</source>             <volume>8</volume>             <fpage>805</fpage>             <lpage>815</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Shilatifard1"><label>78</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Shilatifard</surname><given-names>A</given-names></name>
</person-group>             <year>2008</year>             <article-title>Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation.</article-title>             <source>Curr Opin Cell Biol</source>             <volume>20</volume>             <fpage>341</fpage>             <lpage>348</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Dehe1"><label>79</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dehe</surname><given-names>P. M</given-names></name>
<name name-style="western"><surname>Dichtl</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Schaft</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Roguev</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Pamblanco</surname><given-names>M</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Protein interactions within the Set1 complex and their roles in the regulation of histone 3 lysine 4 methylation.</article-title>             <source>J Biol Chem</source>             <volume>281</volume>             <fpage>35404</fpage>             <lpage>35412</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Ansari1"><label>80</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ansari</surname><given-names>K. I</given-names></name>
<name name-style="western"><surname>Mandal</surname><given-names>S. S</given-names></name>
</person-group>             <year>2010</year>             <article-title>Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing.</article-title>             <source>Febs J</source>             <volume>277(8)</volume>             <fpage>1790</fpage>             <lpage>1804</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Seibler1"><label>81</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Seibler</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Zevnik</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Kuter-Luks</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Andreas</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Kern</surname><given-names>H</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Rapid generation of inducible mouse mutants.</article-title>             <source>Nucleic Acids Res</source>             <volume>31</volume>             <fpage>e12</fpage>          </element-citation></ref>
<ref id="pbio.1000453-AndreuVieyra2"><label>82</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Andreu-Vieyra</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Chen</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Matzuk</surname><given-names>M. M</given-names></name>
</person-group>             <year>2008</year>             <article-title>Conditional deletion of the retinoblastoma (Rb) gene in ovarian granulosa cells leads to premature ovarian failure.</article-title>             <source>Mol Endocrinol</source>             <volume>22</volume>             <fpage>2141</fpage>             <lpage>2161</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Mendez1"><label>83</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Mendez</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Stillman</surname><given-names>B</given-names></name>
</person-group>             <year>2000</year>             <article-title>Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis.</article-title>             <source>Mol Cell Biol</source>             <volume>20</volume>             <fpage>8602</fpage>             <lpage>8612</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Cowell1"><label>84</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cowell</surname><given-names>I. G</given-names></name>
<name name-style="western"><surname>Aucott</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Mahadevaiah</surname><given-names>S. K</given-names></name>
<name name-style="western"><surname>Burgoyne</surname><given-names>P. S</given-names></name>
<name name-style="western"><surname>Huskisson</surname><given-names>N</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>Heterochromatin, HP1 and methylation at lysine 9 of histone H3 in animals.</article-title>             <source>Chromosoma</source>             <volume>111</volume>             <fpage>22</fpage>             <lpage>36</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Conover1"><label>85</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Conover</surname><given-names>J. C</given-names></name>
<name name-style="western"><surname>Temeles</surname><given-names>G. L</given-names></name>
<name name-style="western"><surname>Zimmermann</surname><given-names>J. W</given-names></name>
<name name-style="western"><surname>Burke</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Schultz</surname><given-names>R. M</given-names></name>
</person-group>             <year>1991</year>             <article-title>Stage-specific expression of a family of proteins that are major products of zygotic gene activation in the mouse embryo.</article-title>             <source>Dev Biol</source>             <volume>144</volume>             <fpage>392</fpage>             <lpage>404</lpage>          </element-citation></ref>
<ref id="pbio.1000453-Poueymirou1"><label>86</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Poueymirou</surname><given-names>W. T</given-names></name>
<name name-style="western"><surname>Schultz</surname><given-names>R. M</given-names></name>
</person-group>             <year>1987</year>             <article-title>Differential effects of activators of cAMP-dependent protein kinase and protein kinase C on cleavage of one-cell mouse embryos and protein synthesis and phosphorylation in one- and two-cell embryos.</article-title>             <source>Dev Biol</source>             <volume>121</volume>             <fpage>489</fpage>             <lpage>498</lpage>          </element-citation></ref>
</ref-list><glossary><title>Abbreviations</title><def-list><def-item>
<term> <italic>Amhr2</italic></term>
<def>
<p>anti-Mullerian hormone receptor 2</p>
</def>
</def-item><def-item>
<term><italic>Bax</italic></term>
<def>
<p>Bcl2-associated X protein</p>
</def>
</def-item><def-item>
<term><italic>Casp6</italic></term>
<def>
<p>caspase 6</p>
</def>
</def-item><def-item>
<term><italic>Cdkn1a</italic></term>
<def>
<p>cyclin-dependent kinase inhibitor 1A</p>
</def>
</def-item><def-item>
<term>cKO</term>
<def>
<p>conditional knockout</p>
</def>
</def-item><def-item>
<term>EZH2</term>
<def>
<p>Enhancer of Zeste 2</p>
</def>
</def-item><def-item>
<term><italic>Gdf9</italic></term>
<def>
<p>growth differentiation factor 9</p>
</def>
</def-item><def-item>
<term>H3K4</term>
<def>
<p>histone 3 lysine 4</p>
</def>
</def-item><def-item>
<term><italic>Iap</italic></term>
<def>
<p>intracisternal A particle</p>
</def>
</def-item><def-item>
<term>MLL</term>
<def>
<p>mixed lineage leukemia</p>
</def>
</def-item><def-item>
<term>NSN</term>
<def>
<p>non-surrounding nucleolus</p>
</def>
</def-item><def-item>
<term>PMSG</term>
<def>
<p>pregnant mare serum gonadotropin</p>
</def>
</def-item><def-item>
<term><italic>Setd7</italic></term>
<def>
<p>SET domain lysine methyltransferase 7</p>
</def>
</def-item><def-item>
<term>SN</term>
<def>
<p>surrounded nucleolus</p>
</def>
</def-item><def-item>
<term>WT</term>
<def>
<p>wild type</p>
</def>
</def-item><def-item>
<term>YFP</term>
<def>
<p>yellow fluorescence protein</p>
</def>
</def-item><def-item>
<term>ZGA</term>
<def>
<p>zygotic genome activation</p>
</def>
</def-item><def-item>
<term><italic>Zp3</italic></term>
<def>
<p>zona pellucida 3</p>
</def>
</def-item></def-list></glossary>

</back>
</article>